PROSPECTUS |
Filed
Pursuant to Rule 424(b)(4)
Registration No. 333-141242 |
Per
Share
|
Total
|
||||
Public
offering price
|
$ 16.75
|
$
103,850,000
|
|||
Underwriting
discounts and commissions
|
$
0.84
|
$
5,192,500
|
|||
Proceeds,
before expenses, to us
|
$
15.91
|
$
98,657,500
|
Banc of America Securities LLC | ||
Deutsche Bank Securities | ||
Stifel Nicolaus |
ii
|
|
PROSPECTUS SUMMARY | 1 |
SUMMARY HISTORICAL FINANCIAL INFORMATION | 7 |
9
|
|
9
|
|
9
|
|
9
|
|
11
|
|
11
|
|
12
|
|
13
|
|
14
|
|
14
|
|
15
|
|
15 | |
15
|
|
15
|
|
16
|
|
17
|
|
17
|
|
16
|
|
17
|
|
18
|
|
18
|
|
18
|
19
|
|
19
|
|
20
|
|
20
|
|
20
|
|
20 |
21
|
|
21
|
|
21
|
|
22
|
|
22
|
|
22
|
|
22
|
|
23 | |
24 | |
24 | |
25 | |
25 | |
25 | |
25 | |
26 | |
26 | |
27 | |
CAUTIONARY LANGUAGE REGARDING FORWARD_LOOKING STATEMENTS |
28
|
USE OF PROCEEDS |
29
|
PRICE RANGE OF COMMON STOCK AND DIVIDEND POLICY |
30
|
31
|
|
SELECTED CONSOLIDATED FINANCIAL DATA |
32
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS |
34
|
BUSINESS |
58
|
66 | |
83
|
|
85
|
|
86
|
|
93
|
|
107
|
|
112
|
|
112
|
|
112
|
|
CONSOLIDATED FINANCIAL STATEMENTS | F-1 |
· |
228
long-term healthcare facilities and two rehabilitation hospitals
owned and
leased to third parties; and
|
· |
fixed
rate mortgages on nine long-term healthcare
facilities.
|
Investment
Structure/Operator
|
Number
of
Beds(1)
|
Number
of
Facilities
|
Occupancy
Percentage
(1)
|
Gross
Investment
(in
thousands)
|
Purchase/Leaseback(2)
|
|||||||||||||
Sun
Healthcare Group, Inc.
|
4,523
|
38
|
86
|
% |
$
|
210,222
|
|||||||
CommuniCare
Health Services, Inc.
|
2,781
|
18
|
89
|
185,821
|
|||||||||
Haven
Healthcare
|
1,787
|
15
|
91
|
117,230
|
|||||||||
HQM
of Floyd County, Inc
|
1,466
|
13
|
87
|
98,368
|
|||||||||
Advocat
Inc
|
2,925
|
28
|
78
|
94,432
|
|||||||||
Guardian
LTC Management, Inc.(4)
|
1,308
|
17
|
83
|
85,981
|
|||||||||
Nexion
Health Inc
|
2,412
|
20
|
78
|
80,211
|
|||||||||
Essex
Health Care Corporation
|
1,388
|
13
|
78
|
79,354
|
|||||||||
Seacrest
Healthcare
|
720
|
6
|
92
|
44,223
|
Investment
Structure/Operator
|
Number
of
Beds
|
Number
of
Facilities
|
Occupancy
Percentage
(1)
|
Gross
Investment
(in
thousands)
|
Senior
Management
|
1,413
|
8
|
70
|
35,243
|
|||||||||
Mark
Ide Limited Liability Company
|
832
|
8
|
77
|
25,595
|
|||||||||
Harborside
Healthcare Corporation
|
465
|
4
|
92
|
23,393
|
|||||||||
StoneGate
Senior Care LP
|
664
|
6
|
87
|
21,781
|
|||||||||
Infinia
Properties of Arizona, LLC
|
378
|
4
|
63
|
19,289
|
|||||||||
USA
Healthcare, Inc
|
489
|
5
|
65
|
15,703
|
|||||||||
Rest
Haven Nursing Center, Inc
|
200
|
1
|
90
|
14,400
|
Conifer
Care Communities, Inc.
|
204
|
3
|
89
|
14,367
|
|||||||||
Washington
N&R, LLC
|
286
|
2
|
75
|
12,152
|
|||||||||
Triad
Health Management of Georgia II, LLC
|
304
|
2
|
98
|
10,000
|
|||||||||
Ensign
Group, Inc
|
271
|
3
|
92
|
9,656
|
|||||||||
Lakeland
Investors, LLC
|
300
|
1
|
73
|
8,893
|
|||||||||
Hickory
Creek Healthcare Foundation, Inc.
|
138
|
2
|
85
|
7,250
|
|||||||||
Liberty
Assisted Living Centers, LP
|
120
|
1
|
85
|
5,997
|
|||||||||
Emeritus
Corporation
|
52
|
1
|
66
|
5,674
|
|||||||||
Longwood
Management Corporation(5)
|
185
|
2
|
91
|
5,425
|
|||||||||
Generations
Healthcare, Inc.
|
60
|
1
|
84
|
3,007
|
|||||||||
Skilled
Healthcare(6)
|
59
|
1
|
92
|
2,012
|
|||||||||
Healthcare
Management Services(6)
|
98
|
1
|
48
|
1,486
|
|||||||||
25,828
|
224
|
83
|
1,237,165
|
||||||||||
Assets
Held for Sale
|
|||||||||||||
Active
Facilities(7)
|
354
|
5
|
58
|
3,443
|
|||||||||
Closed
Facility
|
—
|
1
|
—
|
125
|
|||||||||
354
|
6
|
58
|
3,568
|
||||||||||
Fixed
Rate Mortgages(3)
|
|||||||||||||
Advocat
Inc
|
423
|
4
|
82
|
12,587
|
|||||||||
Parthenon
Healthcare, Inc
|
300
|
2
|
73
|
10,730
|
|||||||||
CommuniCare
Health Services, Inc.
|
150
|
1
|
91
|
6,454
|
|||||||||
Texas
Health Enterprises/HEA Mgmt. Group, Inc.
|
147
|
1
|
68
|
1,230
|
|||||||||
Evergreen
Healthcare
|
100
|
1
|
67
|
885
|
|||||||||
1,120
|
9
|
80
|
31,886
|
||||||||||
Total
|
27,302
|
239
|
82
|
$
|
1,272,619
|
(1) |
Represents
the most recent data provided by our
operators.
|
(2) |
Certain of our lease agreements
contain
purchase options that permit the lessees to purchase the underlying
properties from us. Some
of these purchase options could result in us receiving less than
fair
market value for such facility. As of the date of this prospectus,
leases
applicable to approximately 9.16% of our total gross investments
contain
purchase options. The purchase options relating to .16% are currently
exercisable, the purchase options relating to .70% are exercisable
at
specified times during the next four years, and the purchase options
relating to 8.30% are exercisable in ten
years.
|
(3) |
In
general, many of our mortgages contain prepayment provisions that
permit
prepayment of the outstanding principal amounts
thereunder.
|
(4) |
All
17 facilities are subject to a purchase option on September 1,
2015.
|
(5) |
Both
facilities are subject to a purchase option on November 1,
2007.
|
(6) |
The
facility is subject to a purchase option on November 1,
2007.
|
(7) |
Two
facilities representing $1.9 million were purchased on January
31, 2007
pursuant to a purchase
option.
|
· |
the
quality and experience of management and the creditworthiness
of the
operator of the
facility;
|
· |
the
facility’s historical and forecasted cash flow and its ability to meet
operational needs, capital expenditure requirements and lease
or debt
service obligations, providing a competitive return on our
investment;
|
· |
the
construction quality, condition and design of the
facility;
|
· |
the
geographic area of the facility;
|
· |
the
tax, growth, regulatory and reimbursement environment of the jurisdiction
in which the facility is located;
|
· |
the
effect of an investment in such facility on our ability to qualify
as a
REIT;
|
· |
the
occupancy and demand for similar healthcare facilities in the same
or
nearby communities; and
|
· |
the
payor mix of private, Medicare and Medicaid
patients.
|
Common
stock we are offering
|
6,200,000
shares.
|
|
Common
stock to be outstanding immediately after the offering
|
66,300,859 shares.
|
|
New
York Stock Exchange symbol
|
OHI
|
|
Use
of proceeds
|
We
intend to use all of the net proceeds of this offering to repay
indebtedness outstanding under our Credit Facility. If and to the
extent
there are net proceeds remaining after we have repaid all indebtedness
under our Credit Facility, we will use these proceeds for working
capital
and general corporate purposes. See “Use of Proceeds.”
|
|
Risk
factors
|
This
investment involves a high degree of risk. See the section entitled
“Risk
Factors” beginning on page 9 of this prospectus for a discussion of
certain factors you should consider before deciding to invest in
our
common stock.
|
· |
47,244 shares
of
our common stock issuable upon exercise of options outstanding as
of
December 31, 2006 at a weighted average exercise price of $12.70
per
share;
|
· |
1,516,428 shares
of
our common stock available for issuance under our dividend reinvestment
and common stock purchase plan as of December 31,
2006;
|
· |
2,891,980
shares of
our common stock available for future grant under our 2000 Stock
Incentive
Plan and our 2004 Stock Incentive Plan;
and
|
· |
930,000
shares
of
our common stock that may be purchased by underwriters to cover
over-allotments, if any.
|
Year
ended December 31,
|
||||||||||||||||
2002
|
2003
|
2004
|
2005
|
2006
|
||||||||||||
(in
thousands)
|
||||||||||||||||
Operating
data:
|
||||||||||||||||
Revenues:
|
||||||||||||||||
Core
operations
|
$
|
80,572
|
$
|
76,803
|
$
|
86,972
|
$
|
109,644
|
$
|
135,693
|
||||||
Nursing
home operations
|
42,203
|
4,395
|
—
|
—
|
—
|
|||||||||||
Total
revenues
|
122,775
|
81,198
|
86,972
|
109,644
|
135,693
|
|||||||||||
Interest
expense
|
27,381
|
20,802
|
24,902
|
32,021
|
44,126
|
|||||||||||
(Loss)
income from continuing operations
|
(2,561
|
)
|
27,770
|
13,371
|
37,355
|
56,042
|
||||||||||
Net
(loss) income available to common shareholders
|
(32,801
|
)
|
3,516
|
(36,715
|
)
|
25,355
|
45,774
|
|||||||||
Other
financial data:
|
||||||||||||||||
Depreciation
and amortization (1)
|
17,495
|
18,129
|
18,842
|
23,856
|
32,113
|
|||||||||||
Funds
from operations(2)
|
(15,025
|
)
|
25,091
|
(18,474
|
)
|
42,663
|
76,683
|
Twelve
months ended
December
31, 2006
|
|||||||
Actual
|
As
adjusted(3)
|
||||||
Balance
sheet data:
|
(in
thousands)
|
||||||
Cash
|
$
|
729
|
|
729 | |||
Gross
investment
|
1,294,697
|
1,294,697 | |||||
Total
assets
|
1,175,370
|
1,175,370 | |||||
Total
debt(4)
|
676,141
|
577,983 | |||||
Stockholders’
equity
|
465,454
|
563,612 |
Year
ended December 31,
|
||||||||||||||||
2002
|
2003
|
2004
|
2005
|
2006
|
||||||||||||
(in
thousands)
|
||||||||||||||||
Net
income (loss) available to common shareholders
|
(32,801
|
)
|
3,516
|
(36,715
|
)
|
25,355
|
45,774
|
|||||||||
(Deduct
gain) add back loss from real estate dispositions(a)
|
(2,548
|
)
|
149
|
(3,310
|
)
|
(7,969
|
)
|
(1,354
|
)
|
|||||||
(35,349
|
)
|
3,665
|
(40,025
|
)
|
17,386
|
44,420
|
||||||||||
Elimination
of non-cash items included in net income (loss):
|
||||||||||||||||
Depreciation
and amortization(b)
|
21,270
|
21,426
|
21,551
|
25,277
|
32,263
|
|||||||||||
Adjustments
of derivatives to fair market value
|
(946
|
)
|
—
|
—
|
—
|
—
|
||||||||||
FFO
|
(15,025
|
)
|
25,091
|
(18,474
|
)
|
42,663
|
76,683
|
(a)
|
The
add back of loss/deduction of gain from real estate dispositions
includes
the facilities classified as discontinued operations in our audited
consolidated financial statements included in our Annual Reports
on Form
10-K for the three year period ended December 31, 2006.
|
(b)
|
The
add back of depreciation and amortization includes the facilities
classified as discontinued operations in our audited consolidated
financial statements included in our Annual Reports on Form 10-K
for the
three year period ended December 31, 2006. The 2002, 2003, 2004,
2005 and
2006 includes depreciation
of $3.8 million, $3.3 million, $2.7 million, $1.4 million , and $0.2
million, respectively, related to facilities classified as discontinued
operations.
|
(3)
|
As
adjusted basis giving effect to our sale of the common stock in this
offering at an offering price of $16.75 per share and the receipt
of the
estimated net proceeds of this sale of $98.2 million, (after deducting
underwriting discounts and commissions and other expenses of this
offering), and the assumed application of the approximately $98.2
million of net proceeds to repay a portion of our outstanding borrowings
under our
Credit Facility.
|
(4)
|
Total
debt includes long-term debt and current maturities of long-term
debt.
|
· |
applicable
state law;
|
· |
the
parties’ intent;
|
· |
whether
the master lease agreement and related documents were executed
contemporaneously;
|
· |
the
nature and purpose of the relevant
documents;
|
· |
whether
the obligations in various documents are
independent;
|
· |
whether
the leases are coterminous;
|
· |
whether
a single check is paid for all
properties;
|
· |
whether
rent is apportioned among the
leases;
|
· |
whether
termination of one lease constitutes termination of
all;
|
· |
whether
the leases may be separately assigned or
sublet;
|
· |
whether
separate consideration exists for each lease;
and
|
· |
whether
there are cross-default
provisions.
|
· |
whether
rent is calculated to provide a return on investment rather than
to
compensate the lessor for loss, use and possession of the
property;
|
· |
whether
the property is purchased specifically for the lessee’s use or whether the
lessee selected, inspected, contracted for, and received the
property;
|
· |
whether
the transaction is structured solely to obtain tax
advantages;
|
· |
whether
the lessee is entitled to obtain ownership of the property at the
expiration of the lease, and whether any option purchase price is
unrelated to the value of the land;
and
|
· |
whether
the lessee assumed many of the obligations associated with outright
ownership of the property, including responsibility for maintenance,
repair, property taxes and
insurance.
|
· |
Medicare
and Medicaid.
A
significant portion of our SNF operators’ revenue is derived from
governmentally-funded reimbursement programs, primarily Medicare
and
Medicaid, and failure to maintain certification and accreditation
in these
programs would result in a loss of funding from such programs.
Loss of
certification or accreditation could cause the revenues of our
operators
to decline, potentially jeopardizing their ability to meet their
obligations to us. In that event, our revenues from those facilities
could
be reduced, which could in turn cause the value of our affected
properties
to decline. State licensing and Medicare and Medicaid laws also
require
operators of nursing homes and assisted living facilities to comply
with
extensive standards governing operations. Federal and state agencies
administering those laws regularly inspect such facilities and
investigate
complaints. Our operators and their managers receive notices of
potential
sanctions and remedies from time to time, and such sanctions have
been
imposed from time to time on facilities operated by them. If they
are
unable to cure deficiencies, which have been identified or which
are
identified in the future, such sanctions may be imposed and if
imposed may
adversely affect their ability to meet their obligations to us
which could
adversely affect our
revenues.
|
· |
Licensing
and Certification.
Our operators and facilities are subject to regulatory and licensing
requirements of federal, state and local authorities and are periodically
audited by them to confirm compliance. Failure to obtain licensure
or loss
or suspension of licensure would prevent a facility from operating
or
result in a suspension of reimbursement payments until all licensure
issues have been resolved and the necessary licenses obtained or
reinstated. Our SNFs require governmental approval, in the form of
a
certificate of need that generally varies by state and is subject
to
change, prior to the addition or construction of new beds, the addition
of
services or certain capital expenditures. Some of our facilities
may be
unable to satisfy current and future certificate of need requirements
and
may for this reason be unable to continue operating in the future.
In such
event, our revenues from those facilities could be reduced or eliminated
for an extended period of time or
permanently.
|
· |
Fraud
and Abuse Laws and Regulations.
There are various extremely complex and largely uninterpreted federal
and
state laws governing a wide array of referrals, relationships and
arrangements and prohibiting fraud by healthcare providers, including
criminal provisions that prohibit filing false claims or making false
statements to receive payment or certification under Medicare and
Medicaid, or failing to refund overpayments or improper payments.
Federal
and state Governments are devoting increasing attention and resources
to
anti-fraud initiatives against healthcare providers. The Health Insurance
Portability and Accountability Act of 1996 and the Balanced Budget
Act
expanded the penalties for healthcare fraud, including broader provisions
for the exclusion of providers from the Medicare and Medicaid programs.
Furthermore, the Office of Inspector General of the U.S. Department
of
Health and Human Services in cooperation with other federal and state
agencies continues to focus on the activities of SNFs in certain
states in
which we have properties. In addition, the federal False Claims Act
allows
a private individual with knowledge of fraud to bring a claim on
behalf of
the federal government and earn a percentage of the federal government’s
recovery. Because of these incentives, these so-called ‘‘whistleblower’’
suits have become more frequent. The violation of any of these laws
or
regulations by an operator may result in the imposition of fines
or other
penalties that could jeopardize that operator’s ability to make lease or
mortgage payments to us or to continue operating its
facility.
|
· |
Legislative
and Regulatory Developments.
Each year, legislative proposals are introduced or proposed in Congress
and in some state legislatures that would affect major changes in
the
healthcare system, either nationally or at the state level. The Medicare
Prescription Drug, Improvement and Modernization Act of 2003, or
Medicare
Modernization Act, which is one example of such legislation, was
enacted
in late 2003. The Medicare reimbursement changes for the long term
care
industry under this Act are limited to a temporary increase in the
per
diem amount paid to SNFs for residents who have AIDS. The significant
expansion of other benefits for Medicare beneficiaries under this
Act,
such as the expanded prescription drug benefit, could result in financial
pressures on the Medicare program that might result in future legislative
and regulatory changes with impacts for our operators. Other proposals
under consideration include efforts by individual states to control
costs
by decreasing state Medicaid reimbursements, a federal ‘‘Patient
Protection Act’’ to protect consumers in managed care plans, efforts to
improve quality of care and reduce medical errors throughout the
health
care industry and cost-containment initiatives by public and private
payors. We cannot accurately predict whether any proposals will be
adopted
or, if adopted, what effect, if any, these proposals would have on
operators and, thus, our business.
|
· |
the
extent of investor interest;
|
· |
the
general reputation of REITs and the attractiveness of their equity
securities in comparison to other equity securities, including securities
issued by other real estate-based
companies;
|
· |
our
financial performance and that of our
operators;
|
· |
the
contents of analyst reports about us and the REIT
industry;
|
· |
general
stock and bond market conditions, including changes in interest rates
on
fixed income securities, which may lead prospective purchasers of
our
common stock to demand a higher annual yield from future
distributions;
|
· |
our
failure to maintain or increase our dividend, which is dependent,
to a
large part, on growth of funds from operations which in turn depends
upon
increased revenues from additional investments and rental increases;
and
|
· |
other
factors such as governmental regulatory action and changes in REIT
tax
laws.
|
· |
limit
our ability to satisfy our obligations with respect to holders of
our
capital stock;
|
· |
limit
our ability to satisfy the distribution requirements applicable
to
REITs;
|
·
|
increase
our vulnerability to general adverse economic and industry
conditions;
|
· |
limit
our ability to obtain additional financing to fund future working
capital,
capital expenditures and other general corporate requirements, or
to carry
out other aspects of our business
plan;
|
· |
require
us to dedicate a substantial portion of our cash flow from operations
to
payments on indebtedness, thereby reducing the availability of such
cash
flow to fund working capital, capital expenditures and other general
corporate requirements, or to carry out other aspects of our business
plan;
|
· |
require
us to pledge as collateral substantially all of our
assets;
|
· |
require
us to maintain certain debt coverage and financial ratios at specified
levels, thereby reducing our financial
flexibility;
|
· |
limit
our ability to make material acquisitions or take advantage of business
opportunities that may arise;
|
· |
expose
us to fluctuations in interest rates, to the extent our borrowings
bear
variable rates of interests;
|
· |
limit
our flexibility in planning for, or reacting to, changes in our business
and industry; and
|
· |
place
us at a competitive disadvantage compared to our competitors that
have
less debt.
|
· |
the
market for similar securities issued by
REITs;
|
· |
changes
in estimates by analysts;
|
· |
our
ability to meet analysts’
estimates;
|
· |
general
economic and financial market conditions;
and
|
· |
our
financial condition, performance and
prospects.
|
· |
The
issuance and exercise of options to purchase our common stock. As
of
December 31, 2006, we had outstanding options to acquire approximately
0.1 million
shares of our common stock. In addition, we may in the future issue
additional options or other securities convertible into or exercisable
for
our common stock under our 2004 Stock Incentive Plan, our 2000 Stock
Incentive Plan, as amended, or other remuneration plans we establish
in
the future. We may also issue options or convertible securities to
our
employees in lieu of cash bonuses or to our directors in lieu of
director’s fees.
|
· |
The
issuance of shares pursuant to our dividend reinvestment and direct
stock
purchase plan.
|
· |
The
issuance of debt securities exchangeable for our common
stock.
|
· |
The
exercise of warrants we may issue in the
future.
|
· |
Lenders
sometimes ask for warrants or other rights to acquire shares in connection
with providing financing. We cannot assure you that our lenders will
not
request such rights.
|
· |
uncertainties
relating to the business operations of the operators of our assets,
including those relating to reimbursement by third-party payors,
regulatory matters and occupancy
levels;
|
· |
the
ability of any operators in bankruptcy to reject unexpired lease
obligations, modify the terms of our mortgages and impede our ability
to
collect unpaid rent or interest during the process of a bankruptcy
proceeding and retain security deposits for the debtors’
obligations;
|
· |
our
ability to sell closed assets on a timely basis and on terms that
allow us
to realize the carrying value of these
assets;
|
· |
our
ability to negotiate appropriate modifications to the terms of our
Credit
Facility;
|
· |
our
ability to manage, re-lease or sell any owned and operated
facilities;
|
· |
the
availability and cost of capital;
|
· |
competition
in the financing of healthcare
facilities;
|
· |
regulatory
and other changes in the healthcare
sector;
|
· |
the
effect of economic and market conditions generally and, particularly,
in
the healthcare industry;
|
· |
changes
in interest rates;
|
· |
the
amount and yield of any additional
investments;
|
· |
changes
in tax laws and regulations affecting
REITs;
|
· |
our
ability to maintain our status as a real estate investment trust;
and
|
· |
changes
in the ratings of our debt and preferred
securities.
|
High
|
Low
|
Dividends
Per
Share
|
||||||||
Year
ended December 31, 2005
|
||||||||||
First
Quarter
|
$
|
11.95
|
$
|
10.31
|
$
|
0.20
|
||||
Second
Quarter
|
13.65
|
10.58
|
0.21
|
|||||||
Third
Quarter
|
14.28
|
12.39
|
0.22
|
|||||||
Fourth
Quarter
|
13.98
|
11.66
|
0.22
|
|||||||
Year
ended December 31, 2006
|
||||||||||
First
Quarter
|
$
|
14.03
|
$
|
12.36
|
$
|
0.23
|
||||
Second
Quarter
|
13.92
|
11.15
|
0.24
|
|||||||
Third
Quarter
|
15.50
|
12.56
|
0.24
|
|||||||
Fourth
Quarter
|
18.00
|
14.81
|
0.25
|
· |
On
an actual basis; and
|
· |
As
adjusted to give effect to our sale of the common stock in this
offering at an offering price of $16.75 per share and the assumed
application of the approximately $98.2 million of net proceeds
after deducting underwriting discounts and commissions and other
expenses
of this offering to repay borrowings outstanding under our Credit
Facility.
|
As
of December 31, 2006
|
|||||||
Actual
|
As
adjusted
|
||||||
(in
thousands)
|
|||||||
Cash
|
$ |
729
|
$ | 729 | |||
Debt:
|
|||||||
Credit
Facility
|
150,000
|
51,842 | |||||
7.00%
senior notes due 2014
|
310,000
|
310,000 | |||||
Premium
on new 7.00% senior notes due 2014
|
1,148
|
1,148 | |||||
Discount
on 7% Note due 2016
|
(1,417
|
)
|
(1,417 | ) | |||
7.00%
senior notes due 2016
|
175,000
|
175,000 | |||||
Other
long-term borrowings
|
41,410
|
41,410 | |||||
Total
Debt
|
676,141
|
577,983 | |||||
Stockholders’
Equity:
|
|||||||
Preferred
Stock, $1.00 par value; authorized - 20,000 shares:
|
|||||||
Issued
and Outstanding - 4,740 shares Series D with an aggregate liquidation
preference of $118,488 as December 31, 2006
|
118,488
|
118,488 | |||||
Common
Stock, $0.10 par value:
|
|||||||
Authorized
- 100,000 shares
|
|||||||
Issued
and Outstanding - 59,703 as of December 31, 2006; pro forma as
adjusted 65.903 shares
|
5,970
|
6,590 | |||||
Additional
paid in capital
|
694,207
|
791,745 | |||||
Cumulative
net earnings
|
292,766
|
292,766 | |||||
Cumulative
dividends paid
|
(602,910
|
)
|
(602,910 | ) | |||
Cumulative
dividends - redemption
|
(43,067
|
)
|
(43,067 | ) | |||
Total
Stockholders’ Equity
|
465,454
|
563,612 | |||||
Total
Capitalization
|
$ |
1,141,595
|
$ | 1,141,595 |
· |
47,244
shares of
our common stock issuable upon exercise of options outstanding
as of
December
31, 2006
at
a weighted average exercise price of $12.70
per share;
|
· |
1,516,428
shares of
our common stock available for issuance under our dividend reinvestment
and common stock purchase plan as of December
31, 2006;
|
· |
2,891,980
shares of
our common stock available for future grant under our 2000 Stock
Incentive
Plan and our 2004 Stock Incentive Plan;
and
|
· |
930,000
shares
of
our common stock that may be purchased by underwriters to cover
over-allotments, if any.
|
Year
Ended December 31,
|
||||||||||||||||
2002
|
2003
|
2004
|
2005
|
2006
|
||||||||||||
(in
thousands, except per share amounts)
|
||||||||||||||||
Operating data:
Revenues from core operations |
$
|
80,572 |
$
|
76,803 |
$
|
86,972
|
$
|
109,644
|
$
|
135,693
|
||||||
Revenues
from nursing home operations
|
42,203
|
4,395
|
—
|
—
|
—
|
|||||||||||
Total
revenues
|
$
|
122,775 |
$
|
81,198 |
$
|
86,972 |
$
|
109,644
|
$
|
135,693
|
||||||
Income
(loss) from continuing operations
|
$
|
(2,561
|
) |
$
|
27,770
|
$
|
13,371
|
$
|
37,355
|
$
|
56,042
|
|||||
Net
income (loss) available to common
|
(32,801
|
) |
3,516
|
(36,715
|
) |
25,355
|
45,774
|
|||||||||
Per
share amounts:
|
||||||||||||||||
Income
(loss) from continuing operations:
Basic
|
$
|
(0.65
|
) |
$
|
0.21
|
$
|
(0.96
|
) |
$
|
0.46
|
$
|
0.79
|
||||
Diluted
|
|
(0.65
|
) |
0.20
|
(0.96
|
) |
|
0.46
|
|
0.79
|
||||||
Net
income (loss) available to common:
Basic
|
$
|
(0.94
|
) |
$
|
0.09
|
$
|
(0.81
|
) |
$
|
0.49
|
$
|
0.78
|
||||
Diluted
|
(0.94 | ) | 0.09 |
(0.81
|
) |
0.49
|
0.78
|
|||||||||
Dividends,
Common Stock(1)
|
— | 0.15 |
0.72
|
0.85
|
0.96
|
|||||||||||
Dividends,
Series A Preferred(1)
|
—
|
6.94
|
1.16
|
— |
—
|
|||||||||||
Dividends,
Series B Preferred(1)
|
—
|
6.47
|
2.16
|
1.09 |
—
|
|||||||||||
Dividends, Series C Preferred(2) |
—
|
29.81
|
2.72
|
—
|
—
|
|||||||||||
Dividends,
Series D Preferred(1)
|
—
|
—
|
1.52
|
2.09
|
2.09
|
|||||||||||
Weighted-average
common shares outstanding,
basic
|
34,739
|
37,189
|
45,472
|
51,738
|
58,651
|
|||||||||||
Weighted-average
common shares outstanding,
diluted
|
34,739
|
38,154
|
45,472
|
52,059
|
58,745
|
|||||||||||
Other
financial data:
|
||||||||||||||||
Depreciation and amortization (3) | 17,495 | 18,129 |
18,842
|
23,856
|
32,113
|
|||||||||||
Funds from operations(4) | (15,025 | ) | 25,091 |
(18,474
|
) |
42,663
|
76,683
|
|||||||||
Year
Ended December 31,
|
||||||||||||||||
2002
|
2003
|
2004
|
2005
|
2006
|
||||||||||||
Balance
sheet data:
Gross
investments
|
$
|
860,188
|
$
|
821,244
|
$
|
940,747
|
$
|
1,129,753
|
$
|
1,294,697
|
||||||
Total
assets
|
811,096 | 736,775 |
849,576
|
1,036,042
|
1,175,370
|
|||||||||||
Revolving
lines of credit
|
177,000 | 177,074 |
15,000
|
58,000
|
150,000
|
|||||||||||
Other
long-term borrowings
|
129,462 | 103,520 |
364,508
|
508,229
|
526,141
|
|||||||||||
Stockholders’
equity
|
482,995 | 440,130 |
442,935
|
440,943
|
465,454
|
(1) |
Dividends
per share are those declared and paid during such
period.
|
(2) |
Dividends
per share are those declared during such period, based on the number
of
shares of common stock issuable upon conversion of the outstanding
Series
C Preferred Stock.
|
(3) |
Excludes
amounts included in discontinued
operations
|
(4)
|
We
consider funds from operations, or FFO, to be a key measure of a
REIT’s
performance which should be considered along with, but not as an
alternative to, net income and cash flow as a measure of operating
performance and liquidity. We calculate and report FFO in accordance
with
the definition and interpretive guidelines issued by the National
Association of Real Estate Investment Trusts, or NAREIT, and,
consequently, FFO is defined as net income available to common
stockholders, adjusted for the effects of asset dispositions and
certain
non-cash items, primarily depreciation and amortization. We believe
that
FFO is an important supplemental measure of our operating performance.
Because the historical cost accounting convention used for
|
|
real
estate assets requires depreciation (except on land), such accounting
presentation implies that the value of real estate assets diminishes
predictably over time, while real estate values instead have historically
risen or fallen with market conditions. The term FFO was designed
by the
real estate industry to address this issue. FFO herein is not necessarily
comparable to FFO of other REITs that do not use the same definition
of
implementation guidelines or interpret the standards differently
from
us.
|
Year
ended December 31,
|
||||||||||||||||
2002
|
2003
|
2004
|
2005
|
2006
|
||||||||||||
(in
thousands)
|
||||||||||||||||
Net
income (loss) available to common shareholders
|
$ |
(32,801
|
)
|
$ |
3,516
|
$ |
(36,715
|
)
|
$ |
25,355
|
$ |
45,774
|
||||
(Deduct
gain) add back loss from real estate dispositions(a)
|
(2,548
|
)
|
149
|
(3,310
|
)
|
(7,969
|
)
|
(1,354
|
)
|
|||||||
(35,349
|
)
|
3,665
|
(40,025
|
)
|
17,386
|
44,420
|
||||||||||
Elimination
of non-cash items included in net income (loss):
|
||||||||||||||||
Depreciation
and amortization(b)
|
21,270
|
21,426
|
21,551
|
25,277
|
32,263
|
|||||||||||
Adjustments
of derivatives to fair market value
|
(946
|
)
|
—
|
—
|
—
|
—
|
||||||||||
FFO
|
$ |
(15,025
|
)
|
$ |
25,091
|
$ |
(18,474
|
)
|
$ |
42,663
|
$ |
76,683
|
(a)
|
The
add back of loss/deduction of gain from real estate dispositions
includes
the facilities classified as discontinued operations in our audited
consolidated financial statements included in our Annual Reports
on Form
10-K for the three year period ended December 31, 2006.
|
(b)
|
The
add back of depreciation and amortization includes the facilities
classified as discontinued operations in our audited consolidated
financial statements included in our Annual Reports on Form 10-K
for the
three year period ended December 31, 2006. The 2002, 2003, 2004,
2005 and
2006 includes depreciation of $3.8 million, $3.3 million, $2.7 million,
$1.4 million , and $0.2 million, respectively, related to facilities
classified as discontinued
operations.
|
·
|
In
January 2006, we redeemed the remaining 20.7% of our $100 million
aggregate principal amount of our 6.95% notes due 2007 that were
not
otherwise tendered in 2005.
|
·
|
In
2006, we paid common stock dividends of $0.23, $0.24, $0.24 and
$0.25 per
share, for stockholders of record on January 31, 2006, April 28,
2006,
July 31, 2006 and November 3, 2006,
respectively.
|
·
|
In
August 2006, we closed on $171 million of new investments and leased
them
to existing third-party operators.
|
·
|
In
September 2006, we closed on $25.0 million of investments with
an existing
third-party operator.
|
·
|
On
October 20, 2006, we restructured our relationship with Advocat,
which
restructuring included a rent increase of $0.7 million annually
and a term
extension to September 30, 2018.
|
·
|
In
August 2006, we sold our common stock investment in Sun Healthcare
Group,
Inc., or Sun, for $7.6 million of cash
proceeds.
|
·
|
In
June 2006, a $10 million mortgage was paid-off in
full.
|
·
|
In
March 2006, Haven Eldercare, LLC, or Haven, paid $39 million
on a $62
million mortgage it has with
us.
|
·
|
Throughout
2006, in various transactions, we sold three SNFs and one ALF
for cash
proceeds of approximately $1.6 million in the
aggregate.
|
·
|
We
had six assets held for sale as of December 31, 2006 with a net
book value
of approximately $3.6 million. We had eight assets held for sale
as of
December 31, 2005 with a combined net book value of $5.8 million,
which
includes a reclassification of five assets with a net book value
of $4.6
million that were sold or reclassified as held for sale during
2006.
|
· |
During
the three months ended March 31, 2006, a $0.1 million provision
for
impairment charge was recorded to reduce the carrying value to
its sales
price of one facility that was under contract to be sold that was
subsequently sold during the second quarter of 2006. During the
three
months ended December 31, 2006, a $0.4 million impairment charge
was
recorded to reduce the carrying value of two facilities, currently
under
contract to be sold in the first quarter of 2007, to their respective
sales price.
|
·
|
For
the three-month period ended December 31, 2006, we sold an ALF
in Ohio
resulting in an accounting gain of approximately $0.4
million.
|
·
|
For
the three-month period ended June 30, 2006, we sold two SNFs in
California
resulting in an accounting loss of approximately $0.1
million.
|
·
|
For
the three-month period ended March 31, 2006, we sold a SNF in Illinois
resulting in an accounting loss of approximately $0.2
million.
|
·
|
Rental
income was $127.1 million, an increase of $31.6 million over the
same
period in 2005. The increase was due to new leases entered into
throughout
2006 and 2005, as well as rental revenue from the consolidation
of a
variable interest entity, or VIE.
|
·
|
Mortgage
interest income totaled $4.4 million, a decrease of $2.1 million
over the
same period in 2005. The decrease was primarily the result of
normal
amortization, a $60 million loan payoff that occurred in the
first quarter
of 2005 and a $10 million loan payoff that occurred in the second
quarter
of 2006.
|
·
|
Other
investment income totaled $3.7 million, an increase of $0.5 million
over
the same period in 2005. The primary reason for the increase
was due to
dividends and accretion income associated with the Advocat
securities.
|
·
|
Miscellaneous
revenue was $0.5 million, a decrease of $4.0 million over the
same period
in 2005. The decrease was due to contractual revenue owed to
us resulting
from a mortgage note prepayment that occurred in the first quarter
of
2005.
|
·
|
Our
depreciation and amortization expense was $32.1 million, compared
to $23.9
million for the same period in 2005. The increase is due to new
investments placed throughout 2005 and 2006, as well as depreciation
from
the consolidation of a VIE.
|
·
|
Our
general and administrative expense was $13.7 million, compared
to $8.6
million for the same period in 2005. The increase was primarily
due to
$3.4 million of restricted stock amortization expense and compensation
expense related to the performance restricted stock units, $1.2
million of
restatement related expenses and normal inflationary increases
in goods
and services.
|
|
·
|
For
the year ended December 31, 2006, in accordance with FAS No.
123R, we
recorded approximately $3.3 million (included in general and
administrative expense) of compensation expense associated
with the
performance restricted stock units (see Note 12 - Stockholders’ Equity and
Stock Based Compensation to our consolidated financial statements
for the
year ended December 31, 2006 included elsewhere in this
prospectus).
|
·
|
In
2006, we recorded a $0.8 million provision for uncollectible
notes
receivable.
|
·
|
In
2005, we recorded a $1.1 million lease expiration accrual relating
to
disputed capital improvement requirements associated with a lease
that
expired June 30, 2005.
|
·
|
Our
interest expense, excluding amortization of deferred costs and
refinancing
related interest expenses, for the year ended December 31, 2006
was $42.2
million, compared to $29.9 million for the same period in 2005.
The
increase of $13.3 million was primarily due to higher debt on our
balance
sheet versus the same period in 2005 and from consolidation of
interest
expense from a VIE in 2006.
|
·
|
For
the year ended December 31, 2006, we sold our remaining 760,000
shares of
Sun’s common stock for approximately $7.6 million, realizing a gain
on the
sale of these securities of approximately $2.7
million.
|
·
|
For
the year ended December 31, 2006, in accordance with FAS No.
133, we
recorded a $9.1 million fair value adjustment to reflect the
change in
fair value during 2006 of our derivative instrument (i.e., the
conversion
feature of a redeemable convertible preferred stock security
in Advocat, a
publicly traded company; see Note 5 - Other Investments to our
consolidated financial statements for the year ended December
31, 2006
included elsewhere in this
prospectus).
|
·
|
For
the year ended December 31, 2006, we recorded a $3.6 million
gain on
Advocat securities (see Note 5 - Other Investments to our consolidated
financial statements for the year ended December 31, 2006 included
elsewhere in this
prospectus).
|
·
|
For
the year ended December 31, 2006, we recorded a $0.8 million
non-cash
charge associated with the redemption of the remaining $20.7
million
principal amount of our 6.95% unsecured notes due 2007 not otherwise
tendered in 2005.
|
·
|
For
the year ended December 31, 2006, we recorded a one time, non-cash
charge
of approximately $2.7 million relating to the write-off of deferred
financing costs associated with the termination of our prior
credit
facility.
|
·
|
During
the year ended December 31, 2005, we recorded a $3.4 million provision
for
impairment of an equity security. In accordance with FASB No. 115,
the
$3.4 million provision for impairment was to write-down our 760,000
share
investment in Sun’s common stock to its then current fair market
value.
|
·
|
For
the year ended December 31, 2005, we recorded $1.6 million in
net cash
proceeds resulting from settlement of a lawsuit filed suit filed
by us
against a former
tenant.
|
Year
Ended December 31,
|
|||||||
2006
|
2005
|
||||||
Net
income available to common
|
$
|
45,774
|
$
|
25,355
|
|||
Deduct
gain from real estate dispositions(1)
|
(1,354
|
)
|
(7,969
|
)
|
|||
44,420
|
17,386
|
||||||
Elimination
of non-cash items included in net income:
|
|||||||
Depreciation
and amortization(2)
|
32,263
|
25,277
|
|||||
Funds
from operations available to common stockholders
|
$
|
76,683
|
$
|
42,663
|
(1) |
The
deduction of the gain from real estate dispositions includes the
facilities classified as discontinued operations in our consolidated
financial statements included elsewhere in this prospectus. The
gain
deducted includes $1.2 million from a distribution from an investment
in a
limited partnership in 2006 and $0.2 million gain and $8.0 million
gain
related to facilities classified as discontinued operations for
the year
ended December 31, 2006 and 2005,
respectively.
|
(2)
|
The
add back of depreciation and amortization includes the facilities
classified as discontinued operations in our consolidated financial
statements included elsewhere in this prospectus. FFO for 2006
and 2005
includes depreciation and amortization of $0.2 million and $1.4
million,
respectively, related to facilities classified as discontinued
operations.
|
·
|
Rental
income was $95.4 million, an increase of $25.7 million over the
same
period in 2004. The increase was primarily due to new leases
entered into
throughout 2004 and 2005, re-leasing and restructuring
activities.
|
·
|
Mortgage
interest income totaled $6.5 million, a decrease of $6.7 million
over the
same period in 2004. The decrease is primarily the result of
normal
amortization and a $60 million loan payoff that occurred in the
first
quarter of 2005.
|
·
|
Other
investment income totaled $3.2 million, an increase of $0.1 million
over
the same period in 2004. The primary reason for the increase
was due to
dividends and accretion income associated with the Advocat
securities.
|
·
|
Miscellaneous
revenue was $4.5 million, an increase of $3.6 million over the
same period
in 2004. The increase was due to contractual revenue owed to
us as a
result of a mortgage note
prepayment.
|
·
|
Our
depreciation and amortization expense was $23.9 million, compared
to $18.8
million for the same period in 2004. The increase is due to new
investments placed throughout 2004 and
2005.
|
·
|
Our
general and administrative expense was $8.6 million, compared
to $8.8
million for the same period in
2004.
|
·
|
A
$0.1 million provision for uncollectible notes receivable was
recorded in
2005.
|
·
|
A
$1.1 million lease expiration accrual was recorded in 2005 relating
to
disputed capital improvement requirements associated with a lease
that
expired June 30, 2005.
|
·
|
Our
interest expense, excluding amortization of deferred costs and
refinancing
related interest expenses, for the year ended December 31, 2005
was $29.9
million, compared to $23.1
million for the same period 2004. The increase of $6.8 million
was
primarily due to higher debt on our balance sheet versus the
same period
in 2004.
|
·
|
For
the year ended December 31, 2005, we recorded a $2.8 million
non-cash
charge associated with the tender and purchase of $79.3 million
principal amount of our 6.95% unsecured notes due
2007.
|
·
|
For
the year ended December 31, 2005, we recorded a $3.4 million
provision for
impairment on an equity security. In accordance with FASB Statement
No.
115, Accounting
for Certain Investments in Debt and Equity Securities,
we recorded the provision for impairment to write-down our 760,000
share
investment in Sun common stock to its then current fair market
value of
$4.9 million.
|
·
|
For
the year ended December 31, 2004, we recorded $19.1 million of
refinancing-related charges associated with refinancing our capital
structure. The $19.1 million consists of a $6.4 million exit
fee paid to
our old bank syndication and a $6.3 million non-cash deferred
financing
cost write-off associated with the termination of our $225 million
credit
facility and our $50 million acquisition facility, and a loss
of
approximately $6.5 million associated with the sale of an interest
rate
cap.
|
·
|
For
the year ended December 31, 2004, we recorded a $1.1 million
fair value
adjustment to reflect the change in fair value during 2004 of
our
derivative instrument (i.e., the conversion feature of a redeemable
convertible preferred stock security in Advocat, a publicly traded
company; see Note 5 - Other Investments to our consolidated financial
statements for the year ended December 31, 2006 included elsewhere
in this
prospectus).
|
·
|
For
the year ended December 31, 2004, we recorded a $3.0 million
charge
associated with professional liability claims made against our
former
owned and operated
facilities.
|
Year
Ended December 31,
|
|||||||
2005
|
2004
|
||||||
Net
income (loss) available to common
|
$
|
25,355
|
$
|
(36,715
|
)
|
||
Deduct
gain from real estate dispositions(1)
|
(7,969
|
)
|
(3,310
|
)
|
|||
17,386
|
(40,025
|
)
|
|||||
Elimination
of non-cash items included in net income (loss):
|
|||||||
Depreciation
and amortization(2)
|
25,277
|
21,551
|
|||||
Funds
from operations available to common stockholders
|
$
|
42,663
|
$
|
(18,474
|
)
|
(1) |
The
deduction of the gain from real estate dispositions includes the
facilities classified as discontinued operations in our consolidated
financial statements. The gain deducted includes $8.0 million gain
and
$3.3 million gain related to facilities classified as discontinued
operations for the year ended December 31, 2005 and 2004,
respectively.
|
(2)
|
The
add back of depreciation and amortization includes the facilities
classified as discontinued operations in our consolidated financial
statements. FFO for 2005 and 2004 includes depreciation and amortization
of $1.4 million and $2.7 million, respectively, related to facilities
classified as discontinued
operations.
|
Payments
due by period
|
||||||||||||||||
Total
|
Less
than
1
year
|
1-3
years
|
3-5
years
|
More
than
5
years
|
||||||||||||
(in
thousands)
|
||||||||||||||||
Long-term
debt(1)
|
$
|
676,410
|
$
|
415
|
$
|
900
|
$
|
150,785
|
$
|
524,310
|
||||||
Other
long-term liabilities
|
513
|
236
|
277
|
-
|
-
|
|||||||||||
Total
|
$
|
676,923
|
$
|
651
|
$
|
1,177
|
$
|
150,785
|
$
|
524,310
|
(1) |
The
$676.4 million includes $310 million aggregate principal amount of
7.0%
Senior Notes due 2014, $175 million principal amount of 7.0% Senior
Notes
due 2016, $150.0 million borrowings under our Credit
Facility and Haven’s $39 million first mortgage loan with General
electric Capital Corporation that expires in
2012.
|
·
|
normal
recurring expenses;
|
·
|
debt
service payments;
|
·
|
preferred
stock dividends;
|
·
|
common
stock dividends; and
|
·
|
growth
through acquisitions of additional
properties.
|
·
|
228
long-term healthcare facilities and two rehabilitation hospitals
owned and
leased to third parties; and
|
·
|
fixed
rate mortgages on nine long-term healthcare
facilities.
|
·
|
the
quality and experience of management and the creditworthiness of
the
operator of the facility;
|
·
|
the
facility’s historical and forecasted cash flow and its ability to meet
operational needs, capital expenditure requirements and lease or
debt
service obligations, providing a competitive return on our
investment;
|
·
|
the
construction quality, condition and design of the
facility;
|
·
|
the
geographic area of the
facility;
|
·
|
the
tax, growth, regulatory and reimbursement environment of the jurisdiction
in which the facility is located;
|
·
|
the
occupancy and demand for similar healthcare facilities in the same
or
nearby communities; and
|
·
|
the
payor mix of private, Medicare and Medicaid
patients.
|
·
|
4,739,500
shares of Series D cumulative redeemable preferred stock;
|
·
|
An
aggregate of 11,917,736 shares of common stock in registered public
offerings;
|
·
|
$310
million in aggregate principal amount of 7% senior notes due 2014;
and
|
·
|
$175
million in aggregate principal amount of 7% senior notes
due 2016.
|
·
|
the
fact of the common directorship or interest is disclosed to the
board or a
committee of the board, and the board or that committee authorizes
the
contract or transaction by the affirmative vote of a majority of
the
disinterested directors, even if the disinterested directors constitute
less than a quorum;
|
·
|
the
fact of the common directorship or interest is disclosed to stockholders
entitled to vote on the contract or transaction, and the contract
or
transaction is approved by a majority of the votes cast by the
stockholders entitled to vote on the matter, other than votes of
stock
owned of record or beneficially by the interested director, corporation,
firm or other entity; or
|
·
|
the
contract or transaction is fair and reasonable to the
corporation.
|
Investment
Structure/Operator
|
Number
of
Beds(1)
|
Number
of
Facilities
|
Occupancy
Percentage(1)
|
Gross
Investment
(in
thousands)
|
|||||||||
Purchase/Leaseback(2)
|
|||||||||||||
Sun
Healthcare Group, Inc.
|
4,523
|
38
|
86
|
% |
$
|
210,222
|
|||||||
CommuniCare
Health Services, Inc.
|
2,781
|
18
|
89
|
185,821
|
|||||||||
Haven
Healthcare
|
1,787
|
15
|
91
|
117,230
|
|||||||||
HQM
of Floyd County, Inc
|
1,466
|
13
|
87
|
98,368
|
|||||||||
Advocat
Inc
|
2,925
|
28
|
78
|
94,432
|
|||||||||
Guardian
LTC Management, Inc. (4)
|
1,308
|
17
|
83
|
85,981
|
|||||||||
Nexion
Health Inc
|
2,412
|
20
|
78
|
80,211
|
|||||||||
Essex
Health Care Corporation
|
1,388
|
13
|
78
|
79,354
|
|||||||||
Seacrest
Healthcare
|
720
|
6
|
92
|
44,223
|
|||||||||
Senior
Management
|
1,413
|
8
|
70
|
35,243
|
|||||||||
Mark
Ide Limited Liability Company
|
832
|
8
|
77
|
25,595
|
|||||||||
Harborside
Healthcare Corporation
|
465
|
4
|
92
|
23,393
|
|||||||||
StoneGate
Senior Care LP
|
664
|
6
|
87
|
21,781
|
|||||||||
Infinia
Properties of Arizona, LLC
|
378
|
4
|
63
|
19,289
|
Investment
Structure/Operator
|
Number
of
Beds(1)
|
Number
of
Facilities
|
Occupancy
Percentage(1)
|
Gross
Investment
(in
thousands)
|
USA
Healthcare, Inc
|
489
|
5
|
65
|
15,703
|
|||||||||
Rest
Haven Nursing Center, Inc
|
200
|
1
|
90
|
14,400
|
|||||||||
Conifer
Care Communities, Inc.
|
204
|
3
|
89
|
14,367
|
|||||||||
Washington
N&R, LLC
|
286
|
2
|
75
|
12,152
|
|||||||||
Triad
Health Management of Georgia II, LLC
|
304
|
2
|
98
|
10,000
|
|||||||||
Ensign
Group, Inc
|
271
|
3
|
92
|
9,656
|
|||||||||
Lakeland
Investors, LLC
|
300
|
1
|
73
|
8,893
|
|||||||||
Hickory
Creek Healthcare Foundation, Inc.
|
138
|
2
|
85
|
7,250
|
|||||||||
Liberty
Assisted Living Centers, LP
|
120
|
1
|
85
|
5,997
|
|||||||||
Emeritus
Corporation
|
52
|
1
|
66
|
5,674
|
|||||||||
Longwood
Management Corporation (5)
|
185
|
2
|
91
|
5,425
|
|||||||||
Generations
Healthcare, Inc.
|
60
|
1
|
84
|
3,007
|
|||||||||
Skilled
Healthcare (6)
|
59
|
1
|
92
|
2,012
|
|||||||||
Healthcare
Management Services (6)
|
98
|
1
|
48
|
1,486
|
|||||||||
25,828
|
224
|
83
|
1,237,165
|
||||||||||
Assets
Held for Sale
|
|||||||||||||
Active
Facilities (7)
|
354
|
5
|
58
|
3,443
|
|||||||||
Closed
Facility
|
—
|
1
|
—
|
125
|
|||||||||
354
|
6
|
58
|
3,568
|
||||||||||
Fixed
Rate Mortgages(3)
|
|||||||||||||
Advocat
Inc
|
423
|
4
|
82
|
12,587
|
|||||||||
Parthenon
Healthcare, Inc
|
300
|
2
|
73
|
10,730
|
|||||||||
CommuniCare
Health Services, Inc.
|
150
|
1
|
91
|
6,454
|
|||||||||
Texas
Health Enterprises/HEA Mgmt. Group, Inc.
|
147
|
1
|
68
|
1,230
|
|||||||||
Evergreen
Healthcare
|
100
|
1
|
67
|
885
|
|||||||||
1,120
|
9
|
80
|
31,886
|
||||||||||
Total
|
27,302
|
239
|
82
|
$
|
1,272,619
|
(1) |
Represents
the most recent data provided by our
operators.
|
(2) |
Certain
of our lease agreements contain purchase options that permit the
lessees
to purchase the underlying properties from us. Some
of these purchase options could result in us receiving less than
fair
market value for such facility. As of the date of this prospectus,
leases
applicable to approximately 9.16% of our total gross investments
contain
purchase options. The purchase options relating to .16% are currently
exercisable, the purchase options relating to .70% are exercisable
at
specified times during the next four years, and the purchase options
relating to 8.30% are exercisable in ten
years.
|
(3) |
In
general, many of our mortgages contain prepayment provisions that
permit
prepayment of the outstanding principal amounts
thereunder.
|
(4) |
All
17 facilities are subject to a purchase option on September 1,
2015.
|
(5) |
Both
facilities are subject to a purchase option on November 1,
2007.
|
(6) |
The
facility is subject to a purchase option on November 1,
2007.
|
(7) |
Two
facilities representing $1.9 million were purchased on January
31, 2007
pursuant to a purchase
option.
|
Number
of
Facilities
|
Number
of
Beds
|
Gross
Investment
(in
thousands)
|
%
of
Total
Investment
|
||||||||||
Ohio
|
37
|
4,574
|
$
|
278,253
|
21.9
|
||||||||
Florida
|
25
|
3,125
|
172,029
|
13.5
|
|||||||||
Pennsylvania
|
17
|
1,597
|
110,123
|
8.6
|
|||||||||
Texas
|
23
|
3,144
|
83,598
|
6.6
|
|||||||||
California
|
15
|
1,277
|
60,665
|
4.8
|
|||||||||
Louisiana
|
14
|
1,668
|
55,639
|
4.4
|
|||||||||
Colorado
|
8
|
955
|
52,930
|
4.1
|
|||||||||
Arkansas
|
12
|
1,281
|
42,889
|
3.4
|
|||||||||
Massachusetts
|
6
|
682
|
38,884
|
3.1
|
|||||||||
Rhode
Island
|
4
|
639
|
38,740
|
3.0
|
|||||||||
Alabama
|
9
|
1,152
|
35,982
|
2.8
|
|||||||||
Connecticut
|
5
|
562
|
35,453
|
2.8
|
|||||||||
West
Virginia
|
8
|
860
|
34,575
|
2.7
|
|||||||||
Kentucky
|
9
|
757
|
27,485
|
2.2
|
|||||||||
North
Carolina
|
5
|
707
|
22,709
|
1.8
|
|||||||||
Idaho
|
4
|
480
|
21,776
|
1.7
|
|||||||||
New
Hampshire
|
3
|
225
|
21,620
|
1.7
|
|||||||||
Arizona
|
4
|
378
|
19,289
|
1.5
|
|||||||||
Indiana
|
7
|
507
|
17,525
|
1.4
|
|||||||||
Tennessee
|
5
|
602
|
17,484
|
1.4
|
|||||||||
Washington
|
2
|
194
|
17,473
|
1.4
|
|||||||||
Iowa
|
5
|
489
|
15,703
|
1.2
|
|||||||||
Illinois
|
5
|
478
|
14,531
|
1.1
|
|||||||||
Vermont
|
2
|
279
|
14,227
|
1.1
|
|||||||||
Missouri
|
2
|
286
|
12,152
|
0.9
|
|||||||||
Georgia
|
2
|
304
|
10,000
|
0.8
|
|||||||||
Utah
|
1
|
100
|
885
|
0.1
|
|||||||||
Total
|
239
|
27,302
|
$
|
1,272,619
|
100.0
|
Name
|
Age
|
Position
|
||
Bernard
J. Korman(1),(3),(4)
|
75
|
Chairman
of the Board of Directors
|
||
Thomas
F. Franke(1),(4),(6)
|
76
|
Director
|
||
Harold
J. Kloosterman(1),(2),(3),(4),(7)
|
64
|
Director
|
||
Edward
Lowenthal(1),(2),(4)
|
62
|
Director
|
||
Stephen
D. Plavin(1),(2),(4),(5)
|
47
|
Director
|
||
C.
Taylor Pickett(3)
|
45
|
Chief
Executive Officer and Director
|
||
Daniel
J. Booth
|
43
|
Chief
Operating Officer
|
||
R.
Lee Crabill, Jr.
|
53
|
Senior
Vice President of Operations
|
||
Michael Ritz | 38 | Chief Accounting Officer | ||
Robert
O. Stephenson
|
43
|
Chief
Financial Officer
|
·
|
the
members and role of our Compensation Committee, or the Committee;
|
·
|
our
compensation-setting process;
|
·
|
our
compensation philosophy and policies regarding executive compensation;
|
·
|
the
components of our executive compensation program; and
|
·
|
our
compensation decisions for fiscal year 2006 and for the first
quarter of
2007.
|
·
|
The
Committee determines and approves the compensation for the Chief
Executive
Officer and our other executive officers. In doing so, the Committee
evaluates their performance in light of goals and objectives reviewed
by
the Committee and such other factors as the Committee deems appropriate
in
our best interests and in satisfaction of any applicable requirements
of
the New York Stock Exchange and any other legal or regulatory
requirements.
|
·
|
The
Committee reviews and recommends for Board approval (or approves,
where
applicable) the adoption and amendment of our director and executive
officer incentive compensation and equity-based plans. The Committee
has
the responsibility for recommending to the Board the level and
form of
compensation and benefits for
directors.
|
·
|
The
Committee may administer our incentive compensation and equity-based
plans
and may approve such awards thereunder as the Committee deems
appropriate.
|
·
|
The
Committee reviews and monitors succession plans for the Chief Executive
Officer and our other senior
executives.
|
·
|
The
Committee meets to review and discuss with management the CD&A
required by the SEC rules and regulations. The Committee recommends
to the
Board whether the CD&A should be included in our proxy statement or
other applicable SEC filings. The Committee prepares a Compensation
Committee Report for inclusion in our applicable filings with the
SEC.
Such reports state whether the Committee reviewed and discussed
with
management the CD&A, and whether, based on such review and discussion,
the Committee recommended to the Board that the CD&A be included in
our proxy statement or other applicable SEC
filings.
|
·
|
The
Committee should be consulted with respect to any employment agreements,
severance agreements or change of control agreements that are entered
into
between us and any executive
officer.
|
·
|
To
the extent not otherwise inconsistent with its obligations and
responsibilities, the Committee may form subcommittees (which shall
consist of one or more members of the Committee) and delegate authority
to
such subcommittees hereunder as it deems
appropriate.
|
·
|
The
Committee reports to the Board as it deems appropriate and as the
Board
may request.
|
·
|
The
Committee performs such other activities consistent with its charter,
our
Bylaws, governing law, the rules and regulations of the New York
Stock
Exchange and such other requirements applicable to the Company
as the
Committee or the Board deems necessary or
appropriate.
|
·
|
reports
from compensation consultants or legal
counsel;
|
·
|
a
comparison of the compensation of our executives and directors
compared to
its competitors prepared by members of the Committee, by management
at the
Committee’s request or by a compensation consultant engaged by the
Committee;
|
·
|
financial
reports on year-to-date performance versus budget and compared
to prior
year performance, as well as other financial data regarding us
and our
performance;
|
·
|
reports
on our strategic plan and budgets for future
periods;
|
·
|
information
on the executive officers’ stock ownership and option holdings; and
|
·
|
reports
on the levels of achievement of individual and corporate
objectives.
|
·
|
Assist
in attracting and retaining talented and well-qualified
executives;
|
·
|
Reward
performance and initiative;
|
·
|
Be
competitive with other healthcare real estate investment
trusts;
|
·
|
Be
significantly related to accomplishments and our short-term and long-term
successes, particularly measured in terms of growth in funds from
operations on a per share basis;
|
·
|
Align
the interests of our executive officers with the interests of our
stockholders; and
|
·
|
Encourage
executives to achieve meaningful levels of ownership of our
stock.
|
Compensation
Committee of the Board of Directors
/s/
Thomas F. Franke
/s/
Harold J. Kloosterman
/s/
Bernard J. Korman
/s/
Edward Lowenthal
/s/
Stephen D. Plavin
|
Name
and Principal Position
|
Year
|
Salary
($)
|
Bonus
($)
(1)
|
Stock
Awards
($)
(2)
|
Option
Awards
($)
|
Non-Equity
Incentive Plan Compensation ($)
|
Change
in Pension Value and Non-qualified Deferred Compensation
Earnings
|
All
Other Compen-
sation
($)
(3)
|
Total
($)
|
|||||||||||||||||||
Taylor
Pickett (CEO)
|
2006
|
$
|
515,000
|
$
|
463,500
|
$
|
1,317,500
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
343,211
|
$
|
2,639,211
|
|||||||||||
Robert
Stephenson (CFO)
|
2006
|
$
|
255,000
|
$
|
114,750
|
$
|
632,400
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
168,172
|
$
|
1,170,322
|
|||||||||||
Dan
Booth (COO)
|
2006
|
$
|
317,000
|
$
|
158,500
|
$
|
790,500
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
208,566
|
$
|
1,474,566
|
|||||||||||
Lee
Crabill (Sr. VP Operations)
|
2006
|
$
|
246,000
|
$
|
123,000
|
$
|
606,050
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
161,441
|
$
|
1,136,491
|
(1)
|
This
amount represents the bonuses related to the performance in 2006
but paid
in 2007.
|
(2)
|
The
restricted common stock units were granted in 2004 and earned in
2006 because
we attained $0.30 per share of common stock per fiscal quarter in
“Adjusted Funds from Operations,” which target was previously set in 2004
by the Committee, valued at grant date price of $10.54 times the
number of
units earned.
|
(3) |
This
amount
includes: (i)
dividends
on units paid in January 2007 (see footnote 2
above);
|
(ii)
|
interest
earned on dividends on units paid in January 2007 (see footnote 2
above);
|
(iii)
|
dividends
on restricted stock that was paid during 2006, which vested on January
1,
2007; and
|
(iv) |
401(k)
matching contributions.
|
Option
Awards
|
Stock
Awards
|
|||||||||||||||||||||||||||
Name
|
Number
of Securities Underlying Unexercised Options (#)
Exercisable
|
Number
of Securities Underlying Unexercised Options
(#)
Unexercisable
|
Equity
Incentive Plan Awards: Number of Securities Underlying Unexercised
Unearned Options
(#)
|
Option
Exercise Price
($)
|
Option
Expiration
Date
|
Number
of Shares or Units of Stock That Have Not Vested
(#)
(1)
|
Market
Value of Shares or Units of Stock
That
Have Not Vested
($)
(2)
|
Equity
Incentive Plan Awards: Number of Unearned Shares, Units or Other
Rights
That Have Not Vested
(#)
|
Equity
Incentive Plan Awards: Market or Payout Value of Unearned Shares,
Units or
Other Rights That Have Not Vested
($)
|
|||||||||||||||||||
Taylor
Pickett
|
41,666
|
$
|
738,322
|
|||||||||||||||||||||||||
Robert
Stephenson
|
20,000
|
$
|
354,400
|
|||||||||||||||||||||||||
Dan
Booth
|
25,000
|
$
|
443,000
|
|||||||||||||||||||||||||
Lee
Crabill
|
19,166
|
$
|
339,622
|
(1) |
These
balances represent unvested restricted stock at December 31, 2006,
which
subsequently vested on January 1, 2007. These balances exclude performance
restricted stock units, which were vested as of December 31, 2006
but will
be distributed on January 1, 2008. The performance criteria for the
receipt of these units were met in 2006. Messrs. Pickett, Stephenson,
Booth and Crabill were awarded 125,000, 60,000, 75,000 and 57,500
of these
performance restricted stock units, respectively.
|
(2) |
The
market value is based on the closing price of our common stock on
December
29, 2006 of $17.72.
|
Option
Awards
|
Stock
Awards
|
||||||||||||
Name
|
Number
of
Shares Acquired on Exercise (#)
|
Value
Realized on Exercise ($)(1)
|
Number
of
Shares Acquired on Vesting (#)
|
Value
Realized on Vesting ($)
|
|||||||||
Taylor
Pickett
|
—
|
$
|
—
|
—
|
$
|
—
|
|||||||
Robert
Stephenson
|
80,274
|
$
|
785,891
|
—
|
$
|
—
|
|||||||
Dan
Booth
|
91,667
|
$
|
874,837
|
—
|
$
|
—
|
|||||||
Lee
Crabill
|
—
|
$
|
—
|
—
|
$
|
—
|
(1)
|
This
amount represents the gain to the employee based on the market price
of
underlying shares at the date of exercise less the exercise
price.
|
Name
|
Fees
earned or paid in cash
($)
(1)
|
Stock
Awards
($)
|
Option
Awards
($)
|
Non-Equity
Incentive Plan Compensation
($)
|
Change
in Pension Value and Non-Qualified Deferred Compensation
Earnings
|
All
Other Compensation
($)
|
Total
($)
|
|||||||||||||||
Thomas
F. Franke
|
$
|
53,500
|
$
|
27,582
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
81,082
|
||||||||
Harold
J. Kloosterman
|
$
|
69,000
|
$
|
27,582
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
96,582
|
||||||||
Bernard
J. Korman
|
$
|
75,000
|
$
|
52,762
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
127,762
|
||||||||
Edward
Lowenthal
|
$
|
57,500
|
$
|
27,582
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
85,082
|
||||||||
Stephen
D. Plavin
|
$
|
67,500
|
$
|
27,582
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
95,082
|
(1)
|
This
represents the fees earned in 2006 and includes amounts to be paid
in
2007. The amount excludes amounts paid in 2006 but earned in
2005.
|
·
|
each
of our directors and the named executive officers appearing in the
table
under “Executive Compensation — Compensation of Executive Officers”;
and
|
·
|
all
persons known to us to be the beneficial owner of more than 5% of
our
outstanding common stock.
|
Common
Stock
|
Series
D Preferred
|
||||||||||||
Beneficial
Owner
|
Number
of
Shares
|
Percent
of
Class(1)
|
Number
of
Shares
|
Percent
of
Class(19)
|
|||||||||
C.
Taylor Pickett
|
397,742
|
(2)
|
0.7
|
%
|
—
|
—
|
|||||||
Daniel
J. Booth
|
122,889
|
(3)
|
0.2
|
%
|
—
|
—
|
|||||||
R.
Lee Crabill, Jr.
|
91,667
|
(4)
|
0.2
|
%
|
—
|
—
|
|||||||
Robert
O. Stephenson
|
136,458
|
(5)
|
0.2
|
%
|
—
|
—
|
|||||||
Thomas
F. Franke
|
86,176
|
(6)
(7)
|
0.1
|
%
|
—
|
—
|
|||||||
Harold
J. Kloosterman
|
83,597
|
(8)
(9)
|
0.1
|
%
|
—
|
—
|
|||||||
Bernard
J. Korman
|
563,422
|
(10)
|
0.9
|
%
|
—
|
—
|
|||||||
Edward
Lowenthal
|
40,968
|
(11)(12)
|
0.1
|
%
|
—
|
—
|
|||||||
Stephen
D. Plavin
|
33,195
|
(13)
|
0.1
|
%
|
—
|
—
|
|||||||
Directors
and executive officers as a group
(9
persons)
|
1,556,114
|
(14)
|
2.6
|
%
|
—
|
—
|
|||||||
5%
Beneficial Owners:
|
|||||||||||||
ING
Clarion Real Estate Securities, L.P.
|
9,061,903
|
(15)
|
15.1
|
%
|
|||||||||
Nomura
Asset Management Co., LTD.
|
3,934,600
|
(16)
|
6.5
|
%
|
|||||||||
The
Vanguard Group, Inc.
|
3,461,503
|
(17)
|
5.8
|
%
|
|||||||||
ING
Groep N.V.
|
9,713,849
|
(18)
|
16.2
|
%
|
(1)
|
Based
on 60,100,525 shares of our common stock outstanding
as of March 8, 2007.
|
(2)
|
Includes
125,000 shares of restricted common stock that vested on 12/31/06
based on achievement of $0.30 per share of common stock per fiscal
quarter
in “Adjusted Funds from
Operations.”
|
(3)
|
Includes
75,000 shares of restricted common stock that vested on 12/31/06
based on achievement of $0.30 per share of common stock per fiscal
quarter
in “Adjusted Funds from
Operations.”
|
(4)
|
Includes
57,500 shares of restricted common stock that vested on 12/31/06
based on achievement of $0.30 per share of common stock per fiscal
quarter
in “Adjusted Funds from
Operations.”
|
(5)
|
Includes
60,000 shares of restricted common stock that vested on 12/31/06
based on achievement of $0.30 per share of common stock per fiscal
quarter
in “Adjusted Funds from
Operations.”
|
(6)
|
Includes
47,141 shares owned by a family limited liability company (Franke
Family
LLC) of which Mr. Franke is a member.
|
(7)
|
Includes
stock options that are exercisable within 60 days to acquire 4,668
shares.
|
(8)
|
Includes
shares owned jointly by Mr. Kloosterman and his wife, and 10,827
shares
held solely in Mr. Kloosterman’s wife’s name.
|
(9)
|
Includes
stock options that are exercisable within 60 days to acquire 9,000
shares.
|
(10)
|
Includes
stock options that are exercisable within 60 days to acquire 7,001
shares.
|
(11)
|
Includes
1,400 shares owned by his wife through an individual retirement
account.
|
(12)
|
Includes
stock options that are exercisable within 60 days to acquire 7,335
shares.
|
(13)
|
Includes
stock options that are exercisable within 60 days to acquire 14,000
shares.
|
(14)
|
Includes
stock options that are exercisable within 60 days to acquire 42,004
shares
|
(15)
|
Based
on a Schedule 13G filed by ING Clarion Real Estate Securities, L.
P. on
February 12, 2007. ING Clarion Real Estate Securities, L.P. is located
at
259 N. Radnor Chester Road, Suite 205 Radnor, PA 19087. Includes
4,801,428
shares of common stock over which ING Clarion Real Estate Securities,
L.P.
has sole voting power or power to direct the
vote.
|
(16)
|
Based
on a Schedule 13G filed by Nomura Asset Management Co., LTD. on February
12, 2007. Nomura Asset Management Co., LTD. is located at 1-12-1,
Nihonbashi, Chuo-ku, Toyko, Japan 103-8260. Includes 3,934,600 shares
of
common stock over which Nomura Asset Management Co., LTD. has sole
voting
power or power to direct the vote.
|
(17)
|
Based
on a Schedule 13G filed by The Vanguard Group, Inc. on February 14,
2007.
The Vanguard Group, Inc. is located at 100 Vanguard Blvd. Malvern,
PA
19355. Includes 85,883 shares of common stock over which The Vanguard
Group, Inc. has sole voting power or power to direct the
vote.
|
(18)
|
Based
on a Schedule 13G filed by ING Groep N.V. on February 14, 2007. ING
Groep
N.V. is located at Amstelveenseweg 500, 1081 KL Amsterdam, The
Netherlands. Includes 9,713,849 shares of common stock over which
ING
Groep N.V. has sole voting power or power to direct the
vote.
|
(19)
|
Based
on 4,739,500 shares of Series D preferred stock outstanding at March
8,
2007.
|
·
|
by
any means deemed equitable by it to call for the purchase from any
stockholder a number of voting shares sufficient, in the opinion
of our
board of directors, to maintain or bring the direct or indirect ownership
of voting shares of stock of the beneficial owner to a level of no
more
than 9.9% of the outstanding voting shares of our stock;
and
|
·
|
to
refuse to transfer or issue voting shares of stock to any person
whose
acquisition of those voting shares would, in the opinion of our board
of
directors, result in the direct or indirect ownership by that person
of
more than 9.9% of the outstanding voting shares of our
stock.
|
·
|
the
fair market value of the shares reflected in the closing sales price
for
the shares, if then listed on a national securities
exchange;
|
·
|
the
average of the closing sales prices for the shares, if then listed
on more
than one national securities
exchange;
|
·
|
if
the shares are not then listed on a national securities exchange,
the
latest bid quotation for the shares if then traded over-the-counter,
on
the last business day immediately preceding the day on which notices
of
the acquisitions are sent; or
|
·
|
if
none of these closing sales prices or quotations are available, then
the
purchase price will be equal to the net asset value of the stock
as
determined by our board of directors in accordance with the provisions
of
applicable law.
|
·
|
the
designation and stated value per share of such preferred stock and
the
number of shares offered;
|
·
|
the
amount of liquidation preference per
share;
|
·
|
the
initial public offering price at which such preferred stock will
be
issued;
|
·
|
the
dividend rate (or method of calculation), the dates on which dividends
shall be payable and the dates from which dividends shall commence
to
cumulate, if any;
|
·
|
any
redemption or sinking fund
provisions;
|
·
|
any
conversion rights; and
|
·
|
any
additional voting, dividend, liquidation, redemption, sinking fund
and
other rights, preferences, privileges, limitations and
restrictions.
|
·
|
full
dividends (including if such preferred stock is cumulative, dividends
for
prior dividend periods) shall have been paid or declared and set
apart for
payment on all outstanding shares of the preferred stock of such
series
and all other classes and series of preferred stock of the company
(other
than “junior stock” as defined below),
and
|
·
|
we
are not in default or in arrears with respect to the mandatory or
optional
redemption or mandatory repurchase or other mandatory retirement
of, or
with respect to any sinking or other analogous fund for, any shares
of
preferred stock of such series or any shares of any of our other
preferred
stock of any class or series (other than junior
stock),
|
·
|
by
means deemed equitable by it, to call for the purchase from any of
our
stockholders a number of voting shares sufficient, in the opinion
of our
board of directors, to maintain or bring the actual or constructive
ownership of such owner to a level of no more than 9.9% of the value
of
our outstanding capital stock; and
|
·
|
to
refuse to transfer or issue voting shares of our capital stock to
any
person whose acquisition of such voting shares would, in the opinion
of
our board of directors, result in the actual or constructive ownership
by
that person of more than 9.9% of the value of our outstanding capital
stock.
|
·
|
any
merger or consolidation of our company with or into a related
person;
|
·
|
any
sale, lease, exchange, transfer or other disposition, including
without
limitation a mortgage or any other security device, of all or
any
“substantial part,” as defined below, of
|
|
our
assets including, without limitation, any voting securities of a
subsidiary to a related person;
|
·
|
any
merger or consolidation of a related person with or into our
company;
|
·
|
any
sale, lease, exchange, transfer or other disposition of all or any
substantial part of the assets of a related person to our
company;
|
·
|
the
issuance of any securities (other than by way of pro rata distribution
to
all stockholders) of our company to a related person;
and
|
·
|
any
agreement, contract or other arrangement providing for any of the
transactions described in the definition of business
combination.
|
·
|
that
we acquire as the result of having bid on such property at foreclosure,
or
having otherwise reduced such property to ownership or possession
by
agreement or process of law, after there was a default or default
was
imminent on a lease of such property or on indebtedness that such
property
secured;
|
·
|
for
which we acquired the related loan or lease at a time when the
default was
not imminent or anticipated; and
|
·
|
for
which we make a proper election to treat the property as foreclosure
property.
|
·
|
on
which a lease is entered into for the property that, by its terms,
will
give rise to income that does not qualify for purposes of the 75%
gross
income test, or any amount is received or accrued, directly or indirectly,
pursuant to a lease entered into on or after such day that will give
rise
to income that does not qualify for purposes of the 75% gross income
test;
|
·
|
on
which any construction takes place on the property, other than completion
of a building or any other improvement, where more than 10% of the
construction was completed before default became imminent; or
|
·
|
which
is more than 90 days after the day on which the REIT acquired the
property
and the property is used in a trade or business which we conduct,
other
than through an independent contractor from whom the REIT itself
does not
derive or receive any income. Income
that we derive from an independent contractor with respect to a qualified
healthcare facility is disregarded if such income is derived pursuant
to a
lease in effect at the time we acquire the facility, through renewal
of
such a lease according to its terms, or through a lease entered into
on
substantially similar terms.
|
·
|
85%
of our REIT ordinary income for such year;
|
·
|
95%
of our REIT capital gain income for such year; and
|
·
|
any
undistributed taxable income from prior periods,
|
· |
are
a corporation or come within certain other exempt categories and
when
required, demonstrate this fact; or
|
· |
provide
a taxpayer identification number, certify as to no loss of exemption
from
backup withholding, and otherwise comply with applicable requirements
of
the backup withholding rules.
|
· |
the
REIT would not qualify for federal income tax purposes but for the
application of a “look-through” exception to the “five or fewer”
requirement applicable to shares held by qualified trusts;
and
|
· |
the
REIT is “predominantly held” by qualified trusts, meaning
that:
|
· |
a
single qualified trust holds more than 25% by value of the REIT interests;
or
|
· |
one
or more qualified trusts, each owning more than 10% by value of the
REIT
interests, hold in the aggregate more than 50% by value of the REIT
interests.
|
· |
a
lower treaty rate applies, you file an IRS Form W-8BEN with us and
other conditions are met; or
|
· |
you
file an IRS Form W-8ECI with us claiming that the distribution is
effectively connected income, and other conditions are
met.
|
· |
investment
in the shares is effectively connected with your U.S. trade or business,
in which case you will be subject to the same treatment as U.S.
stockholders with respect to the gain;
or
|
· |
you
are a nonresident alien individual who was present in the United
States
for more than 182 days during the taxable year and other applicable
requirements are met, in which case you will be subject to a 30%
tax on
your capital gains.
|
· |
the
payment is made through an office outside the U.S. of a broker that
is:
(a) a U.S. person; (b) a foreign person that derives 50% or more
of its gross income for certain periods from the conduct of a trade
or
business in the U.S.; or (c) a “controlled foreign corporation” for
U.S. federal income tax purposes;
and
|
· |
the
broker fails to initiate documentary evidence that you are a Non-U.S.
Stockholder and that certain conditions are met or that you otherwise
are
entitled to an exemption.
|
Underwriters
|
Number
of shares
|
||
UBS Securities LLC |
2,480,000
|
||
Banc of America Securities LLC | 1,240,000 | ||
Deutsche Bank Securities Inc. | 1,240,000 | ||
Stifel, Nicolaus & Company, Incorporated | 1,240,000 | ||
Total
|
6,200,000 |
· |
receipt
and acceptance of our common stock by the underwriters,
and
|
· |
the
underwriters’ right to reject orders in whole or in
part.
|
No
exercise
|
Full
exercise
|
||||
Per
share
|
$
0.8375
|
$
0.8375
|
|||
Total
|
$ 5,192,500
|
$
5,971,375
|
· |
stabilizing
transactions;
|
· |
short
sales;
|
· |
purchases
to cover positions created by short
sales;
|
· |
imposition
of penalty bids;
|
· |
syndicate
covering transactions; and
|
· |
passive
market making.
|
Title
of Document
|
Page
Number
|
Report
of Independent Registered Public Accounting Firm
|
F-2
|
Consolidated
Balance Sheets as of December 31, 2006 and 2005
|
F-3
|
Consolidated
Statements of Operations for the years ended December
31, 2006, 2005 and 2004
|
F-4
|
Consolidated
Statements of Stockholders’ Equity for the years ended December
31, 2006, 2005 and 2004
|
F-5
|
Consolidated
Statements of Cash Flows for the years ended December
31, 2006, 2005 and 2004
|
F-9
|
Notes
to Consolidated Financial Statements
|
F-10
|
Schedule
III - Real Estate and Accumulated Depreciation
|
F-42
|
Schedule
IV - Mortgage Loans on Real Estate
|
F-45
|
December
31,
|
|||||||
2006
|
2005
|
||||||
ASSETS
|
|||||||
Real
estate properties
|
|||||||
Land
and buildings at cost
|
$
|
1,237,165
|
$
|
990,492
|
|||
Less
accumulated depreciation
|
(188,188
|
)
|
(156,198
|
)
|
|||
Real
estate properties – net
|
1,048,977
|
834,294
|
|||||
Mortgage
notes receivable – net
|
31,886
|
104,522
|
|||||
1,080,863
|
938,816
|
||||||
Other
investments – net
|
22,078
|
28,918
|
|||||
1,102,941
|
967,734
|
||||||
Assets
held for sale – net
|
3,568
|
5,821
|
|||||
Total
investments
|
1,106,509
|
973,555
|
|||||
Cash
and cash equivalents
|
729
|
3,948
|
|||||
Restricted
cash
|
4,117
|
5,752
|
|||||
Accounts
receivable –net
|
51,194
|
15,018
|
|||||
Other
assets
|
12,821
|
37,769
|
|||||
Total
assets
|
$
|
1,175,370
|
$
|
1,036,042
|
|||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|||||||
Revolving
line of credit
|
$
|
150,000
|
$
|
58,000
|
|||
Unsecured
borrowings
|
484,731
|
505,429
|
|||||
Other
long –
term borrowings
|
41,410
|
2,800
|
|||||
Accrued
expenses and other liabilities
|
28,037
|
25,315
|
|||||
Income
tax liabilities
|
5,646
|
3,299
|
|||||
Operating
liabilities for owned properties
|
92
|
256
|
|||||
Total
liabilities
|
709,916
|
595,099
|
|||||
Stockholders’
equity:
|
|||||||
Preferred
stock issued and outstanding – 4,740 shares Class D with an aggregate
liquidation preference of $118,488
|
118,488
|
118,488
|
|||||
Common
stock $.10 par value authorized – 100,000 shares: Issued and
outstanding – 59,703 shares in 2006 and 56,872 shares in
2005
|
5,970
|
5,687
|
|||||
Common
stock and additional paid-in-capital
|
694,207
|
657,920
|
|||||
Cumulative
net earnings
|
292,766
|
237,069
|
|||||
Cumulative
dividends paid
|
(602,910
|
)
|
(536,041
|
)
|
|||
Cumulative
dividends – redemption
|
(43,067
|
)
|
(43,067
|
)
|
|||
Unamortized
restricted stock awards
|
—
|
(1,167
|
)
|
||||
Accumulated
other comprehensive income
|
—
|
2,054
|
|||||
Total
stockholders’ equity
|
465,454
|
440,943
|
|||||
Total
liabilities and stockholders’ equity
|
$
|
1,175,370
|
$
|
1,036,042
|
Year
Ended December 31,
|
||||||||||
2006
|
2005
|
2004
|
||||||||
Revenues
|
||||||||||
Rental
income
|
$
|
127,072
|
$
|
95,439
|
$
|
69,746
|
||||
Mortgage
interest
income
|
4,402
|
6,527
|
13,266
|
|||||||
Other
investment income –
net
|
3,687
|
3,219
|
3,129
|
|||||||
Miscellaneous
|
532
|
4,459
|
831
|
|||||||
Total
operating revenues
|
135,693
|
109,644
|
86,972
|
|||||||
Expenses
|
||||||||||
Depreciation
and
amortization
|
32,113
|
23,856
|
18,842
|
|||||||
General
and
administrative
|
13,744
|
8,587
|
8,841
|
|||||||
Provision
for impairment on real
estate properties
|
—
|
—
|
—
|
|||||||
Provisions
for uncollectible
mortgages, notes and accounts receivable
|
792
|
83
|
—
|
|||||||
Leasehold
expiration
expense
|
—
|
1,050
|
—
|
|||||||
Total
operating expenses
|
46,649
|
33,576
|
27,683
|
|||||||
Income
before other income and expense
|
89,044
|
76,068
|
59,289
|
|||||||
Other
income (expense):
|
||||||||||
Interest
and other investment
income
|
413
|
220
|
122
|
|||||||
Interest
expense
|
(42,174
|
)
|
(29,900
|
)
|
(23,050
|
)
|
||||
Interest
–
amortization
of
deferred financing costs
|
(1,952
|
)
|
(2,121
|
)
|
(1,852
|
)
|
||||
Interest
–
refinancing
costs
|
(3,485
|
)
|
(2,750
|
)
|
(19,106
|
)
|
||||
Gain
on sale of equity
securities
|
2,709
|
—
|
—
|
|||||||
Gain
on investment
restructuring
|
3,567
|
—
|
—
|
|||||||
Provisions
for impairment on
equity securities
|
—
|
(3,360
|
)
|
—
|
||||||
Litigation
settlements and
professional liability claims
|
—
|
1,599
|
(3,000
|
)
|
||||||
Change
in fair value of
derivatives
|
9,079
|
(16
|
)
|
1,361
|
||||||
Total
other expense
|
(31,843
|
)
|
(36,328
|
)
|
(45,525
|
)
|
||||
Income
before gain on assets sold
|
57,201
|
39,740
|
13,764
|
|||||||
Gain
from assets sold - net
|
1,188
|
—
|
—
|
|||||||
Income
from continuing operations before income
taxes
|
58,389
|
39,740
|
13,764
|
|||||||
Provision
for income taxes
|
(2,347
|
)
|
(2,385
|
)
|
(393
|
)
|
||||
Income
from continuing operations
|
56,042
|
37,355
|
13,371
|
|||||||
(Loss)
income from discontinued operations
|
(345
|
)
|
1,398
|
6,775
|
||||||
Net
income
|
55,697
|
38,753
|
20,146
|
|||||||
Preferred
stock dividends
|
(9,923
|
)
|
(11,385
|
)
|
(15,807
|
)
|
||||
Preferred
stock conversion and redemption charges
|
—
|
(2,013
|
)
|
(41,054
|
)
|
|||||
Net
income (loss) available to common
|
$
|
45,774
|
$
|
25,355
|
$
|
(36,715
|
)
|
|||
Income
(loss) per common share:
|
||||||||||
Basic:
|
||||||||||
Income
(loss) from continuing
operations
|
$
|
0.79
|
$
|
0.46
|
$
|
(0.96
|
)
|
|||
Net
income (loss)
|
$
|
0.78
|
$
|
0.49
|
$
|
(0.81
|
)
|
|||
Diluted:
|
||||||||||
Income
(loss) from continuing
operations
|
$
|
0.79
|
$
|
0.46
|
$
|
(0.96
|
)
|
|||
Net
income (loss)
|
$
|
0.78
|
$
|
0.49
|
$
|
(0.81
|
)
|
|||
Dividends
declared and paid per common share
|
$
|
0.96
|
$
|
0.85
|
$
|
0.72
|
||||
Weighted
– average shares outstanding, basic
|
58,651
|
51,738
|
45,472
|
|||||||
Weighted
– average shares outstanding, diluted
|
58,745
|
52,059
|
45,472
|
|||||||
Components
of other comprehensive income:
|
||||||||||
Net
income
|
$
|
55,697
|
$
|
38,753
|
$
|
20,146
|
||||
Unrealized
gain (loss) on common stock investment
|
1,580
|
1,384
|
(1,224
|
)
|
||||||
Reclassification
adjustment for gains on common stock investment
|
(1,740
|
)
|
—
|
—
|
||||||
Reclassification
adjustment for gains on preferred stock investment
|
(1,091
|
)
|
—
|
—
|
||||||
Unrealized
(loss) gain on preferred stock investment
and
hedging contracts –
net
|
(803
|
)
|
(1,258
|
)
|
7,607
|
|||||
Total
comprehensive income
|
$
|
53,643
|
$
|
38,879
|
$
|
26,529
|
Common
Stock
Par
Value
|
Additional
Paid-in
Capital
|
Preferred
Stock
|
Cumulative
Net
Earnings
|
||||||||||
Balance
at December 31, 2003 (37,291 common shares)
|
3,729
|
481,467
|
212,342
|
178,170
|
|||||||||
Issuance
of common stock:
|
|||||||||||||
Grant
of restricted stock (318 shares at $10.54 per share)
|
—
|
3,346
|
—
|
—
|
|||||||||
Amortization
of restricted stock
|
—
|
—
|
—
|
—
|
|||||||||
Dividend
reinvestment plan (16 shares at $9.84 per share)
|
2
|
157
|
—
|
—
|
|||||||||
Exercised
options (1,190 shares at an average exercise price of $2.775 per
share)
|
119
|
(403
|
)
|
—
|
—
|
||||||||
Grant
of stock as payment of directors fees (10 shares at an average
of $10.3142
per share)
|
1
|
101
|
—
|
—
|
|||||||||
Equity
offerings (2,718 shares at $9.85 per share)
|
272
|
23,098
|
—
|
—
|
|||||||||
Equity
offerings (4,025 shares at $11.96 per share)
|
403
|
45,437
|
—
|
—
|
|||||||||
Net
income for 2004
|
—
|
—
|
—
|
20,146
|
|||||||||
Purchase
of Explorer common stock (11,200 shares)
|
(1,120
|
)
|
(101,025
|
)
|
—
|
—
|
|||||||
Common
dividends paid ($0.72 per share)
|
—
|
—
|
—
|
—
|
|||||||||
Issuance
of Series D preferred stock (4,740 shares)
|
—
|
(3,700
|
)
|
118,488
|
—
|
||||||||
Series
A preferred redemptions
|
—
|
2,311
|
(57,500
|
)
|
—
|
||||||||
Series
C preferred stock conversions
|
1,676
|
103,166
|
(104,842
|
)
|
—
|
||||||||
Series
C preferred stock redemptions
|
—
|
38,743
|
—
|
—
|
|||||||||
Preferred
dividends paid (Series A of $1.156 per share, Series B of $2.156
per share
and Series D of $1.518 per share)
|
—
|
—
|
—
|
—
|
|||||||||
Reclassification
for realized loss on sale of interest rate cap
|
—
|
—
|
—
|
—
|
|||||||||
Unrealized
loss on Sun common stock investment
|
—
|
—
|
—
|
—
|
|||||||||
Unrealized
gain on Advocat securities
|
—
|
—
|
—
|
—
|
|||||||||
Balance
at December 31, 2004 (50,824 common shares)
|
5,082
|
592,698
|
168,488
|
198,316
|
|||||||||
Issuance
of common stock:
|
|||||||||||||
Grant
of restricted stock (7 shares at $11.03 per share)
|
—
|
77
|
—
|
—
|
|||||||||
Amortization
of restricted stock
|
—
|
—
|
—
|
—
|
|||||||||
Vesting
of restricted stock (grants 66 shares)
|
7
|
(521
|
)
|
—
|
—
|
||||||||
Dividend
reinvestment plan (573 shares at $12.138 per share)
|
57
|
6,890
|
—
|
—
|
|||||||||
Exercised
options (218 shares at an average exercise price of $2.837 per
share)
|
22
|
(546
|
)
|
—
|
—
|
||||||||
Grant
of stock as payment of directors fees (9 shares at an average of
$11.735
per share)
|
1
|
99
|
—
|
—
|
|||||||||
Equity
offerings (5,175 shares at $11.80 per share)
|
518
|
57,223
|
—
|
—
|
|||||||||
Net
income for 2005
|
—
|
—
|
—
|
38,753
|
|||||||||
Common
dividends paid ($0.85 per share)
|
—
|
—
|
—
|
—
|
|||||||||
Series
B preferred redemptions
|
—
|
2,000
|
(50,000
|
)
|
—
|
||||||||
Preferred
dividends paid (Series B of $1.090 per share and Series D of $2.0938
per
share)
|
—
|
—
|
—
|
—
|
|||||||||
Reclassification
for realized loss on Sun common stock investment
|
—
|
—
|
—
|
—
|
|||||||||
Unrealized
loss on Sun common stock investment
|
—
|
—
|
—
|
—
|
|||||||||
Unrealized
gain on Advocat securities
|
—
|
—
|
—
|
—
|
|||||||||
Balance
at December 31, 2005 (56,872 common shares)
|
5,687
|
657,920
|
118,488
|
237,069
|
Common
Stock
Par
Value
|
Additional
Paid-in
Capital
|
Preferred
Stock
|
Cumulative
Net
Earnings
|
Balance
at December 31, 2005 (56,872 common shares)
|
5,687
|
657,920
|
118,488
|
237,069
|
Impact
of adoption of FAS No. 123(R)
|
—
|
(1,167
|
)
|
—
|
—
|
||||||||
Issuance
of common stock:
|
|||||||||||||
Grant
of restricted stock (7 shares at $12.59 per share)
|
1
|
(1
|
)
|
—
|
—
|
||||||||
Amortization
of restricted stock
|
—
|
4,517
|
—
|
—
|
|||||||||
Vesting
of restricted stock (grants 90 shares)
|
9
|
(247
|
)
|
—
|
—
|
||||||||
Dividend
reinvestment plan (2,558 shares at $12.967 per share)
|
256
|
32,840
|
—
|
—
|
|||||||||
Exercised
options (170 shares at an average exercise price of $2.906 per
share)
|
17
|
446
|
—
|
—
|
|||||||||
Grant
of stock as payment of directors fees (6 shares at an average of
$12.716
per share)
|
—
|
77
|
—
|
—
|
|||||||||
Costs
for 2005 equity offerings
|
—
|
(178
|
)
|
—
|
—
|
||||||||
Net
income for 2006
|
—
|
—
|
—
|
55,697
|
|||||||||
Common
dividends paid ($0.96 per share)
|
—
|
—
|
—
|
—
|
|||||||||
Preferred
dividends paid (Series D of $2.094 per share)
|
—
|
—
|
—
|
—
|
|||||||||
Reclassification
for realized gain on Sun common stock investment
|
—
|
—
|
—
|
—
|
|||||||||
Unrealized
gain on Sun common stock investment
|
—
|
—
|
—
|
—
|
|||||||||
Reclassification
for unrealized gain on Advocat securities
|
—
|
—
|
—
|
—
|
|||||||||
Unrealized
loss on Advocat securities
|
—
|
—
|
—
|
—
|
|||||||||
Balance
at December 31, 2006 (59,703 common shares)
|
$
|
5,970
|
$
|
694,207
|
$
|
118,488
|
$
|
292,766
|
Cumulative
Dividends |
Unamortized
Restricted Stock Awards
|
Accumulated
Other Comprehensive Loss
|
Total
|
||||||||||
Balance
at December 31, 2003 (37,291 common shares)
|
(431,123
|
)
|
—
|
(4,455
|
)
|
440,130
|
|||||||
Issuance
of common stock:
|
|||||||||||||
Grant
of restricted stock (318 shares at $10.54 per share)
|
—
|
(3,346
|
)
|
—
|
—
|
||||||||
Amortization
of restricted stock
|
—
|
1,115
|
—
|
1,115
|
|||||||||
Dividend
reinvestment plan (16 shares)
|
—
|
—
|
—
|
159
|
|||||||||
Exercised
options (1,190 shares at an average exercise price of $2.775
per
share)
|
—
|
—
|
—
|
(284
|
)
|
||||||||
Grant
of stock as payment of directors fees (10 shares at an average
of
$10.3142
per share)
|
—
|
—
|
—
|
102
|
|||||||||
Equity
offerings (2,718 shares)
|
—
|
—
|
—
|
23,370
|
|||||||||
Equity
offerings (4,025 shares)
|
—
|
—
|
—
|
45,840
|
|||||||||
Net
income for 2004
|
—
|
—
|
—
|
20,146
|
|||||||||
Purchase
of Explorer common stock (11,200 shares).
|
—
|
—
|
—
|
(102,145
|
)
|
||||||||
Common
dividends paid ($0.72 per share).
|
(32,151
|
)
|
—
|
—
|
(32,151
|
)
|
|||||||
Issuance
of Series D preferred stock (4,740 shares)
|
—
|
—
|
—
|
114,788
|
|||||||||
Series
A preferred stock redemptions
|
(2,311
|
)
|
—
|
—
|
(57,500
|
)
|
|||||||
Series
C preferred stock conversions
|
—
|
—
|
—
|
—
|
|||||||||
Series
C preferred stock redemptions
|
(38,743
|
)
|
—
|
—
|
—
|
||||||||
Preferred
dividends paid (Series A of $1.156 per share, Series B of $2.156
per
share
and Series D of $1.518 per share)
|
(17,018
|
)
|
—
|
—
|
(17,018
|
)
|
|||||||
Reclassification
for realized loss on sale of interest rate cap
|
—
|
—
|
6,014
|
6,014
|
|||||||||
Unrealized
loss on Sun common stock investment
|
—
|
—
|
(2,783
|
)
|
(2,783
|
)
|
|||||||
Unrealized
gain on Advocat securities
|
—
|
—
|
3,152
|
3,152
|
|||||||||
Balance
at December 31, 2004 (50,824 common shares)
|
(521,346
|
)
|
(2,231
|
)
|
1,928
|
442,935
|
|||||||
Issuance
of common stock:
|
|||||||||||||
Grant
of restricted stock (7 shares at $11.03 per share)
|
—
|
(77
|
)
|
—
|
—
|
||||||||
Amortization
of restricted stock
|
—
|
1,141
|
—
|
1,141
|
|||||||||
Vesting
of restricted stock (grants 66 shares)
|
—
|
—
|
—
|
(514
|
)
|
||||||||
Dividend
reinvestment plan (573 shares at $12.138 per share)
|
—
|
—
|
—
|
6,947
|
|||||||||
Exercised
options (218 shares at an average exercise price of
$2.837 per
share)
|
—
|
—
|
—
|
(524
|
)
|
||||||||
Grant
of stock as payment of directors fees (9 shares at an average
of
$11.735
per
share)
|
—
|
—
|
—
|
100
|
|||||||||
Equity
offerings (5,175 shares at $11.80 per share)
|
—
|
—
|
—
|
57,741
|
|||||||||
Net
income for 2005
|
—
|
—
|
—
|
38,753
|
|||||||||
Common
dividends paid ($0.85 per share).
|
(43,645
|
)
|
—
|
—
|
(43,645
|
)
|
|||||||
Series
B preferred redemptions
|
(2,013
|
)
|
—
|
—
|
(50,013
|
)
|
|||||||
Preferred
dividends paid (Series B of $1.090 per share and Series D of
$2.0938 per
share)
|
(12,104
|
)
|
—
|
—
|
(12,104
|
)
|
|||||||
Reclassification
for realized loss on Sun common stock investment
|
—
|
—
|
3,360
|
3,360
|
|||||||||
Unrealized
loss on Sun common stock investment
|
—
|
—
|
(1,976
|
)
|
(1,976
|
)
|
|||||||
Unrealized
loss on Advocat securities
|
—
|
—
|
(1,258
|
)
|
(1,258
|
)
|
|||||||
Balance
at December 31, 2005 (56,872 common shares)
|
(579,108
|
)
|
(1,167
|
)
|
2,054
|
440,943
|
Cumulative
Dividends |
Unamortized
Restricted Stock Awards
|
Accumulated
Other Comprehensive Loss
|
Total
|
Balance
at December 31, 2005 (56,872 common shares)
|
(579,108
|
)
|
(1,167
|
)
|
2,054
|
440,943
|
Impact
of adoption of FAS No. 123(R)
|
—
|
1,167
|
—
|
—
|
|||||||||
Issuance
of common stock:
|
|||||||||||||
Grant
of restricted stock (7 shares at $12.590 per share)
|
—
|
—
|
—
|
—
|
|||||||||
Amortization
of restricted stock
|
—
|
—
|
—
|
4,517
|
|||||||||
Vesting
of restricted stock (grants 90 shares)
|
—
|
—
|
—
|
(238
|
)
|
||||||||
Dividend
reinvestment plan (2,558 shares at $12.967 per share)
|
—
|
—
|
—
|
33,096
|
|||||||||
Exercised
options (170 shares at an average exercise price of
$2.906 per
share)
|
—
|
—
|
—
|
463
|
|||||||||
Grant
of stock as payment of directors fees (6 shares at an average
of
$12.716
per
share)
|
—
|
—
|
—
|
77
|
|||||||||
Costs
for 2005 equity offerings
|
—
|
—
|
—
|
(178
|
)
|
||||||||
Net
income for 2006
|
—
|
—
|
—
|
55,697
|
|||||||||
Common
dividends paid ($0.96 per share)
|
(56,946
|
)
|
—
|
—
|
(56,946
|
)
|
|||||||
Preferred
dividends paid (Series D of $2.094 per share)
|
(9,923
|
)
|
—
|
—
|
(9,923
|
)
|
|||||||
Reclassification
for realized gain on Sun common stock investment
|
—
|
—
|
(1,740
|
)
|
(1,740
|
)
|
|||||||
Unrealized
gain on Sun common stock investment
|
—
|
—
|
1,580
|
1,580
|
|||||||||
Reclassification
for unrealized gain on Advocat securities
|
—
|
—
|
(1,091
|
)
|
(1,091
|
)
|
|||||||
Unrealized
loss on Advocat securities
|
—
|
—
|
(803
|
)
|
(803
|
)
|
|||||||
Balance
at December 31, 2006 (59,703 common shares)
|
$
|
(645,977
|
)
|
$
|
—
|
$
|
—
|
$
|
465,454
|
Year
Ended December 31,
|
||||||||||
2006
|
2005
|
2004
|
||||||||
Cash
flow from operating activities
|
||||||||||
Net
income
|
$
|
55,697
|
$
|
38,753
|
$
|
20,146
|
||||
Adjustment
to reconcile net income to cash provided by operating
activities:
|
||||||||||
Depreciation
and amortization (including amounts in discontinued
operations)
|
32,263
|
25,277
|
21,551
|
|||||||
Provisions
for impairment (including amounts in discontinued operations)
|
541
|
9,617
|
—
|
|||||||
Provisions
for uncollectible mortgages, notes and accounts
receivable (including amounts in discontinued operations)
|
944
|
83
|
—
|
|||||||
Provision
for impairment on equity securities
|
—
|
3,360
|
—
|
|||||||
Income
from accretion of marketable securities to redemption value
|
(1,280
|
)
|
(1,636
|
)
|
(810
|
)
|
||||
Refinancing
costs
|
3,485
|
2,750
|
19,106
|
|||||||
Amortization
for deferred finance costs
|
1,952
|
2,121
|
1,852
|
|||||||
(Gain)
loss on assets and equity securities sold –
net (incl.
amounts in discontinued operations)
|
(4,063
|
)
|
(7,969
|
)
|
(3,358
|
)
|
||||
Gain
on investment restructuring
|
(3,567
|
)
|
—
|
—
|
||||||
Restricted
stock amortization expense
|
4,517
|
1,141
|
1,115
|
|||||||
Adjustment
of derivatives to fair value
|
(9,079
|
)
|
16
|
(1,361
|
)
|
|||||
Other
|
(61
|
)
|
(1,521
|
)
|
(55
|
)
|
||||
Net
change in accounts receivable
|
(64
|
)
|
2,150
|
(742
|
)
|
|||||
Net
change in straight – line rent
|
(6,158
|
)
|
(5,284
|
)
|
(4,136
|
)
|
||||
Net
change in lease inducement
|
(19,965
|
)
|
—
|
—
|
||||||
Net
change in other assets
|
2,558
|
4,075
|
(72
|
)
|
||||||
Net
change in income tax liabilities
|
2,347
|
2,385
|
394
|
|||||||
Net
change in other operating assets and liabilities
|
2,744
|
(1,252
|
)
|
2,028
|
||||||
Net
cash provided by operating activities
|
62,811
|
74,066
|
55,658
|
|||||||
Cash
flow from investing activities
|
||||||||||
Acquisition
of real estate
|
(178,906
|
)
|
(248,704
|
)
|
(114,214
|
)
|
||||
Placement
of mortgage loans
|
—
|
(61,750
|
)
|
(6,500
|
)
|
|||||
Proceeds
from sale of stock
|
7,573
|
—
|
480
|
|||||||
Proceeds
from sale of real estate investments
|
2,406
|
60,513
|
5,672
|
|||||||
Capital
improvements and funding of other investments
|
(6,806
|
)
|
(3,821
|
)
|
(5,606
|
)
|
||||
Proceeds
from other investments and assets held for sale – net
|
37,937
|
6,393
|
9,145
|
|||||||
Investments
in other investments- net
|
(34,445
|
)
|
(9,574
|
)
|
(3,430
|
)
|
||||
Collection
of mortgage principal
|
10,886
|
61,602
|
8,226
|
|||||||
Net
cash used in investing activities
|
(161,355
|
)
|
(195,341
|
)
|
(106,227
|
)
|
||||
Cash
flow from financing activities
|
||||||||||
Proceeds
from credit line borrowings
|
262,800
|
387,800
|
157,700
|
|||||||
Payments
of credit line borrowings
|
(170,800
|
)
|
(344,800
|
)
|
(319,774
|
)
|
||||
Payment
of re – financing related costs
|
(3,194
|
)
|
(7,818
|
)
|
(16,591
|
)
|
||||
Proceeds
from long-term borrowings
|
39,000
|
223,566
|
261,350
|
|||||||
Payments
of long – term borrowings
|
(390
|
)
|
(79,688
|
)
|
(350
|
)
|
||||
Payment
to Trustee to redeem long-term borrowings
|
—
|
(22,670
|
)
|
—
|
||||||
Proceeds
from sale of interest rate cap
|
—
|
—
|
3,460
|
|||||||
Receipts
from Dividend Reinvestment Plan
|
33,096
|
6,947
|
262
|
|||||||
Receipts/(payments)
for exercised options – net
|
225
|
(1,038
|
)
|
(387
|
)
|
|||||
Dividends
paid
|
(66,869
|
)
|
(55,749
|
)
|
(49,169
|
)
|
||||
Redemption
of preferred stock
|
—
|
(50,013
|
)
|
(57,500
|
)
|
|||||
Proceeds
from preferred stock offering
|
—
|
—
|
12,643
|
|||||||
Proceeds
from common stock offering
|
—
|
57,741
|
69,210
|
|||||||
Payment
on common stock offering
|
(178
|
)
|
(29
|
)
|
—
|
|||||
Other
|
1,635
|
(1,109
|
)
|
(1,296
|
)
|
|||||
Net
cash provided by financing activities
|
95,325
|
113,140
|
59,558
|
|||||||
(Decrease)
increase in cash and cash equivalents
|
(3,219
|
)
|
(8,135
|
)
|
8,989
|
|||||
Cash
and cash equivalents at beginning of year
|
3,948
|
12,083
|
3,094
|
|||||||
Cash
and cash equivalents at end of year
|
$
|
729
|
$
|
3,948
|
$
|
12,083
|
||||
Interest
paid during the year
|
$
|
34,995
|
$
|
31,354
|
$
|
19,150
|
Year
Ended December 31,
|
||||||||||
2006
|
2005
|
2004
|
||||||||
(in
thousands, except per share amounts)
|
||||||||||
Net
income (loss) to common stockholders
|
$
|
45,774
|
$
|
25,355
|
$
|
(36,715
|
)
|
|||
Add:
Stock-based compensation expense included in net income (loss) to
common
stockholders
|
4,517
|
1,141
|
1,115
|
|||||||
50,291
|
26,496
|
(35,600
|
)
|
|||||||
Less:
Stock-based compensation expense determined under the fair value
based
method for all awards
|
4,517
|
1,319
|
1,365
|
|||||||
Pro
forma net income (loss) to common stockholders
|
$
|
45,774
|
$
|
25,177
|
$
|
(36,965
|
)
|
|||
Earnings
per share:
|
||||||||||
Basic,
as reported
|
$
|
0.78
|
$
|
0.49
|
$
|
(0.81
|
)
|
|||
Basic,
pro forma
|
$
|
0.78
|
$
|
0.49
|
$
|
(0.81
|
)
|
|||
Diluted,
as reported
|
$
|
0.78
|
$
|
0.49
|
$
|
(0.81
|
)
|
|||
Diluted,
pro forma
|
$
|
0.78
|
$
|
0.48
|
$
|
(0.81
|
)
|
Significant
Weighted-Average Assumptions:
|
|
|
|
|
Risk-free
Interest Rate at time of Grant
|
|
|
2.50
|
%
|
Expected
Stock Price Volatility
|
|
|
3.00
|
%
|
Expected
Option Life in Years (a)
|
|
|
4
|
|
Expected
Dividend Payout
|
|
|
5.00
|
%
|
(a) |
Expected
life is based on contractual expiration
dates
|
December
31,
|
|||||||
2006
|
2005
|
||||||
(in
thousands)
|
|||||||
Buildings
|
$
|
1,166,010
|
$
|
934,341
|
|||
Land
|
71,155
|
56,151
|
|||||
1,237,165
|
990,492
|
||||||
Less
accumulated depreciation
|
(188,188
|
)
|
(156,198
|
)
|
|||
Total
|
$
|
1,048,977
|
$
|
834,294
|
(in
thousands)
|
||||
2007
|
$
|
133,958
|
||
2008
|
132,868
|
|||
2009
|
134,454
|
|||
2010
|
134,322
|
|||
2011
|
124,632
|
|||
Thereafter
|
404,852
|
|||
$
|
1,065,086
|
2006
Acquisitions
|
||
100%
Interest Acquired
|
Acquisition
Date
|
Purchase
Price ($000’s)
|
Thirty
one facilities in CO, FL, ID, LA, TX
|
August
1, 2006
|
$171,400
|
One
Facility in PA
|
September
1, 2006
|
5,800
|
2005
Acquisitions
|
||
100%
Interest Acquired
|
Acquisition
Date
|
Purchase
Price ($000’s)
|
Thirteen
facilities in OH
|
January
13, 2005
|
$79,300
|
Two
facilities in TX
|
June
1, 2005
|
9,500
|
Five
facilities in PA and OH
|
June
28, 2005
|
49,600
|
Three
facilities in TX
|
November
1, 2005
|
12,800
|
Eleven
facilities in OH
|
December
16, 2005
|
115,300
|
Pro
forma
Year
Ended December 31,
|
||||||||||
2006
|
2005
|
2004
|
||||||||
(in
thousands, except per share amount, unaudited)
|
||||||||||
Revenues
|
$
|
146,683
|
$
|
145,369
|
$
|
116,344
|
||||
Net
income
|
$
|
56,862
|
$
|
42,110
|
$
|
24,232
|
||||
Earnings
per share – pro forma:
|
||||||||||
Earnings
(loss) per share – Basic
|
$
|
0.80
|
$
|
0.55
|
$
|
(0.72
|
)
|
|||
Earnings
(loss) per share – Diluted
|
$
|
0.80
|
$
|
0.55
|
$
|
(0.72
|
)
|
·
|
We
had six assets held for sale as of December 31, 2006 with a net
book value
of approximately $3.6 million. We had eight assets held for sale
as of
December 31, 2005 with a combined net book value of $5.8 million,
which
includes a reclassification of five assets with a net book value
of $4.6
million that were sold or reclassified as held for sale during
2006.
|
·
|
During
the three
months ended March 31, 2006, a
$0.1 million provision for impairment charge was recorded to reduce
the
carrying value to its sales price of one facility that was under
contract
to be sold that was subsequently sold during the second quarter
of
2006.
During the three months ended December 31, 2006, a $0.4 million
impairment
charge was recorded to reduce the carrying value of two
facilities, currently under contract to be sold in the first quarter
of
2007, to their respective sales
price.
|
·
|
During
the year ended December 31, 2005, a combined $9.6 million provision
for
impairment charge was recorded to reduce the carrying value on
several
facilities, some of which were subsequently closed, to their estimated
fair values.
|
·
|
For
the three-month period ending December 31, 2006, we sold an ALF
in Ohio
resulting in an accounting gain of approximately $0.4
million.
|
·
|
For
the three-month period ending June 30, 2006, we sold two SNFs in
California resulting in an accounting loss of approximately $0.1
million.
|
·
|
For
the three-month period ending March 31, 2006, we sold a SNF in
Illinois
resulting in an accounting loss of approximately $0.2
million.
|
·
|
In
November 2005, we sold a SNF in Florida for net cash proceeds of
approximately $14.1 million, resulting in a gain of approximately
$5.8
million.
|
·
|
In
August 2005, we sold 50.4 acres of undeveloped land, located
in Ohio, for
net cash proceeds of approximately $1 million. The sale resulted
in a gain
of approximately $0.7
million.
|
·
|
In
March 2005, we sold three facilities, located in Florida and
California,
for their approximate net book value realizing cash proceeds
of
approximately $6 million, net of closing costs and other
expenses.
|
·
|
During
2004, we sold six closed facilities, realizing proceeds of approximately
$5.7 million, net of closing costs and other expenses, resulting
in a net
gain of approximately $3.3
million.
|
December
31,
|
||||||||
2006
|
2005
|
|||||||
(in
thousands)
|
||||||||
Mortgage
note due 2014; monthly payment of $63,707, including interest at
11.00%
|
6,454
|
6,496
|
||||||
Mortgage
note due 2010; monthly payment of $124,833, including interest at
11.50%
|
12,587
|
12,634
|
||||||
Mortgage
note due 2016; monthly interest only payment of $118,931 at
11.50%
|
10,730
|
10,732
|
||||||
Mortgage
note paid off 2nd
quarter 2006, interest rate was 10.00%
|
—
|
9,991
|
||||||
Mortgage
note due 2012; interest only at 10% (1)
|
—
|
61,750
|
||||||
Other
mortgage notes
|
2,115
|
2,919
|
||||||
Total
mortgages—net (2)
|
$
|
31,886
|
$
|
104,522
|
(1) |
As
a
result of the application of FIN 46R in 2006, we consolidated the
Haven
entity that was the debtor on this mortgage note. Our balance sheet
at
December 31, 2006 reflects real estate assets of $62 million, reflecting
the real estate owned by the Haven
entity.
|
(2) |
Mortgage
notes are shown net of allowances of $0.0 million in 2006 and
2005.
|
At
December 31,
|
|||||||
2006
|
2005
|
||||||
(in
thousands)
|
|||||||
Notes
receivable(1)
|
$
|
17,071
|
$
|
21,039
|
|||
Notes
receivable allowance
|
(1,512
|
)
|
(2,412
|
)
|
|||
Marketable
securities and other
|
6,519
|
10,291
|
|||||
Total
other investments
|
$
|
22,078
|
$
|
28,918
|
(1)
|
Includes
notes receivable deemed impaired in 2006 and 2005 of $0 million
and $1.8
million, respectively.
|
·
|
In
accordance with FASB Statement No. 115, Accounting
for Certain Investments in Debt and Equity Securities (“FAS
No. 115”), in June 2005, we recorded a $3.4 million provision for
impairment to write-down our 760,000 share investment in Sun common
stock
to its then current fair market value of $4.9 million. At December
31,
2005, the fair value of our Sun stock investment was $5.0
million.
|
·
|
During
the three months ended September 30, 2006, we sold our remaining
760,000
shares of Sun’s common stock for approximately $7.6 million, realizing a
gain on the sale of these securities of approximately $2.7
million.
|
December
31,
|
|||||||
2006
|
2005
|
||||||
(in
thousands)
|
|||||||
Unsecured
borrowings:
|
|||||||
6.95%
Notes due January 2006
|
$
|
—
|
$
|
20,682
|
|||
7%
Notes due August 2014
|
310,000
|
310,000
|
|||||
7%
Notes due January 2016
|
175,000
|
175,000
|
|||||
Haven
– GE Loan due October 2012
|
39,000
|
—
|
|||||
Premium
on 7% Notes due August 2014
|
1,148
|
1,306
|
|||||
Discount
on 7% Notes due January 2016
|
(1,417
|
)
|
(1,559
|
)
|
|||
Other
long-term borrowings
|
2,410
|
2,800
|
|||||
526,141
|
508,229
|
||||||
Secured
borrowings:
|
|||||||
Revolving
lines of credit
|
150,000
|
58,000
|
|||||
Totals
|
$
|
676,141
|
$
|
566,229
|
(in
thousands)
|
||||
2007
|
$
|
415
|
||
2008
|
435
|
|||
2009
|
465
|
|||
2010
|
150,495
|
|||
2011
|
290
|
|||
Thereafter
|
524,310
|
|||
Totals
|
$
|
676,410
|
2006
|
2005
|
||||||||||||
Carrying
Amount
|
Fair
Value
|
Carrying
Amount
|
Fair
Value
|
||||||||||
Assets:
|
(in
thousands)
|
||||||||||||
Cash
and cash equivalents
|
$
|
729
|
$
|
729
|
$
|
3,948
|
$
|
3,948
|
|||||
Restricted
cash
|
4,117
|
4,117
|
5,752
|
5,752
|
|||||||||
Mortgage
notes receivable – net
|
31,886
|
31,975
|
104,522
|
105,981
|
|||||||||
Other
investments
|
22,078
|
20,996
|
28,918
|
29,410
|
|||||||||
Totals
|
$
|
58,810
|
$
|
57,817
|
$
|
143,140
|
$
|
145,091
|
|||||
Liabilities:
|
|||||||||||||
Revolving
lines of credit
|
$
|
150,000
|
$
|
150,000
|
$
|
58,000
|
$
|
58,000
|
|||||
6.95%
Notes
|
—
|
—
|
20,682
|
20,674
|
|||||||||
7.00%
Notes due 2014
|
310,000
|
317,116
|
310,000
|
315,007
|
|||||||||
7.00%
Notes due 2016
|
175,000
|
182,826
|
175,000
|
172,343
|
|||||||||
(Discount)/Premium
on 7.00% Notes – net
|
(269
|
)
|
(121
|
)
|
(253
|
)
|
(86
|
)
|
|||||
Other
long-term borrowings
|
41,410
|
43,868
|
2,800
|
2,791
|
|||||||||
Totals
|
$
|
676,141
|
$
|
693,689
|
$
|
566,229
|
$
|
568,729
|
·
|
Cash
and cash equivalents: The carrying amount of cash and cash equivalents
reported in the balance sheet approximates fair value because of
the short
maturity of these instruments (i.e., less than 90
days).
|
·
|
Mortgage
notes receivable: The fair values of the mortgage notes receivables
are
estimated using a discounted cash flow analysis, using interest
rates
being offered for similar loans to borrowers with similar credit
ratings.
|
·
|
Other
investments: Other investments are primarily comprised of: (i)
notes
receivable; (ii) a redeemable non-convertible preferred security
in 2006
and a redeemable convertible preferred security in 2005; (iii)
an embedded
derivative of the redeemable convertible preferred security in
2005; (iv)
a subordinated debt instrument of a publicly traded company; and
(v) a
marketable common stock security held for resale in 2005. The fair
values
of notes receivable are estimated using a discounted cash flow
analysis,
using interest rates being offered for similar loans to borrowers
with
similar credit ratings. The fair value of the embedded derivative
is
estimated using a
financial pricing model and market data derived from the underlying
issuer’s common stock. The
fair value of the marketable securities are estimated using discounted
cash flow and volatility assumptions or, if available, a quoted
market
value.
|
·
|
Revolving
lines of credit: The carrying values of our borrowings under variable
rate
agreements approximate their fair
values.
|
·
|
Senior
notes and other long-term borrowings: The fair value of our borrowings
under fixed rate agreements are estimated based on open market
trading
activity provided by a third party.
|
Option
Price
Range
|
Number
|
Weighted
Average Exercise Price
|
Weighted
Average Remaining Life (Years)
|
Number
Exercisable
|
Weighted
Average Price on Options Exercisable
|
|||||||||||
$2.96
-$3.81
|
11,918
|
$
|
3.41
|
3.44
|
11,918
|
$
|
3.41
|
|||||||||
$6.02
-$9.33
|
22,330
|
$
|
6.67
|
5.14
|
20,661
|
$
|
6.46
|
|||||||||
$20.25
-$37.20
|
14,665
|
$
|
29.04
|
1.59
|
14,665
|
$
|
29.04
|
Stock
Options
|
Number
of
Shares |
Exercise
Price
|
Weighted-
Average Price |
Weighted-
Average Remaining Contractual Term |
Aggregate
Intrinsic
Value
|
|||||||||||
Outstanding
at December 31, 2003
|
2,282,630
|
|
$
2.320 - $ 37.205
|
$
|
3.202
|
6.8
|
||||||||||
Granted
during
2004
|
9,000
|
9.330
- 9.330
|
9.330
|
|||||||||||||
Exercised
|
(1,713,442
|
)
|
2.320
- 7.750
|
2.988
|
||||||||||||
Cancelled
|
(8,005
|
)
|
3.740
- 9.330
|
6.914
|
||||||||||||
Outstanding
at December 31, 2004
|
570,183
|
2.320
- 37.205
|
3.891
|
6.0
|
||||||||||||
Exercised
|
(336,910
|
)
|
2.320
- 9.330
|
2.843
|
||||||||||||
Cancelled
|
(5,833
|
)
|
3.410
- 3.410
|
3.410
|
||||||||||||
Outstanding
at December 31, 2005
|
227,440
|
2.760
- 37.205
|
5.457
|
4.6
|
||||||||||||
Exercised
|
(174,191
|
)
|
2.760
- 9.330
|
2.979
|
||||||||||||
Cancelled
|
(4,336
|
)
|
22.452
- 25.038
|
24.594
|
||||||||||||
Outstanding
at December 31, 2006
|
48,913
|
$ 2.960
- $ 37.205
|
$
|
12.583
|
3.1
|
$
|
417,368
|
|||||||||
Exercisable
at December 31, 2006
|
47,244
|
$
2.960-
$37.205
|
$
|
12.698
|
3.7
|
$
|
403,357
|
Restricted
Stock
|
Number
of Shares
|
Weighted-Average
Grant-Date Fair Value
|
|||||
Non-vested
at December 31, 2005
|
218,666
|
$
|
10.56
|
||||
Granted
during
2006
|
7,000
|
12.59
|
|||||
Vested
|
(108,170
|
)
|
10.55
|
||||
Non-vested
at December 31, 2006
|
117,496
|
$
|
10.68
|
Performance
Restricted Stock Units
|
Number
of Units
|
Weighted-Average
Grant-Date Fair Value
|
|||||
Non-vested
at December 31, 2005
|
317,500
|
$
|
10.54
|
||||
Vested
|
(317,500
|
)
|
10.54
|
||||
Non-vested
at December 31, 2006
|
—
|
$
|
—
|
2006
|
2005
|
2004
|
||||||||
Common
|
||||||||||
Ordinary
income
|
$
|
0.560
|
$
|
0.550
|
$
|
—
|
||||
Return
of capital
|
0.400
|
0.300
|
0.720
|
|||||||
Long-term
capital gain
|
—
|
—
|
—
|
|||||||
Total
dividends paid
|
$
|
0.960
|
$
|
0.850
|
$
|
0.720
|
||||
Series
A Preferred
|
||||||||||
Ordinary
income
|
$
|
—
|
$
|
—
|
$
|
0.901
|
||||
Return
of capital
|
—
|
—
|
0.255
|
|||||||
Long-term
capital gain
|
—
|
—
|
—
|
|||||||
Total
dividends paid
|
$
|
—
|
$
|
—
|
$
|
1.156
|
||||
Series
B Preferred
|
||||||||||
Ordinary
income
|
$
|
—
|
$
|
1.090
|
$
|
1.681
|
||||
Return
of capital
|
—
|
—
|
0.475
|
|||||||
Long-term
capital gain
|
—
|
—
|
—
|
|||||||
Total
dividends paid
|
$
|
—
|
$
|
1.090
|
$
|
2.156
|
||||
Series
C Preferred
|
||||||||||
Ordinary
income
|
$
|
—
|
$
|
—
|
$
|
2.120
|
||||
Return
of capital
|
—
|
—
|
0.600
|
|||||||
Long-term
capital gain
|
—
|
—
|
—
|
|||||||
Total
dividends paid
|
$
|
—
|
$
|
—
|
$
|
2.720
|
||||
Series
D Preferred
|
||||||||||
Ordinary
income
|
$
|
2.094
|
$
|
2.094
|
$
|
1.184
|
||||
Return
of capital
|
—
|
—
|
0.334
|
|||||||
Long-term
capital gain
|
—
|
—
|
—
|
|||||||
Total
dividends paid
|
$
|
2.094
|
$
|
2.094
|
$
|
1.518
|
March
31
|
June
30
|
September
30
|
December
31
|
||||||||||
(in
thousands, except per share amounts)
|
|||||||||||||
2006
|
|||||||||||||
Revenues
|
$
|
32,067
|
$
|
32,314
|
$
|
35,151
|
$
|
36,161
|
|||||
Income
from continuing operations
|
10,494
|
17,565
|
14,751
|
13,232
|
|||||||||
(Loss)
income from discontinued operations
|
(319
|
)
|
(75
|
)
|
(128
|
)
|
177
|
||||||
Net
income
|
10,175
|
17,490
|
14,623
|
13,409
|
|||||||||
Net
income available to common
|
7,694
|
15,009
|
12,143
|
10,928
|
|||||||||
Income
from continuing operations per share:
|
|||||||||||||
Basic
income from continuing
operations
|
$
|
0.14
|
$
|
0.26
|
$
|
0.21
|
$
|
0.18
|
|||||
Diluted
income from continuing
operations
|
$
|
0.14
|
$
|
0.26
|
$
|
0.21
|
$
|
0.18
|
|||||
Net
income available to common per share:
|
|||||||||||||
Basic
net income
|
$
|
0.13
|
$
|
0.26
|
$
|
0.21
|
$
|
0.18
|
|||||
Diluted
net
income
|
$
|
0.13
|
$
|
0.26
|
$
|
0.20
|
$
|
0.18
|
|||||
Cash
dividends paid on common stock
|
$
|
0.23
|
$
|
0.24
|
$
|
0.24
|
$
|
0.25
|
|||||
2005
|
|||||||||||||
Revenues
|
$
|
28,131
|
$
|
26,165
|
$
|
26,997
|
$
|
28,351
|
|||||
Income
from continuing operations
|
12,402
|
5,604
|
9,811
|
9,538
|
|||||||||
(Loss)
income from discontinued operations
|
(2,752
|
)
|
(3,157
|
)
|
(4,127
|
)
|
11,434
|
||||||
Net
income
|
9,650
|
2,447
|
5,684
|
20,972
|
|||||||||
Net
income (loss) available to common
|
6,091
|
(2,430
|
)
|
3,203
|
18,491
|
||||||||
Income
from continuing operations per share:
|
|||||||||||||
Basic
income from continuing
operations
|
$
|
0.17
|
$
|
0.01
|
$
|
0.14
|
$
|
0.13
|
|||||
Diluted
income from continuing
operations
|
$
|
0.17
|
$
|
0.01
|
$
|
0.14
|
$
|
0.13
|
|||||
Net
income (loss) available to common per share:
|
|||||||||||||
Basic
net income
(loss)
|
$
|
0.12
|
$
|
(0.05
|
)
|
$
|
0.06
|
$
|
0.34
|
||||
Diluted
net income
(loss)
|
$
|
0.12
|
$
|
(0.05
|
)
|
$
|
0.06
|
$
|
0.34
|
||||
Cash
dividends paid on common stock
|
$
|
0.20
|
$
|
0.21
|
$
|
0.22
|
$
|
0.22
|
Year
Ended December 31,
|
||||||||||
2006
|
2005
|
2004
|
||||||||
(in
thousands, except per share amounts)
|
||||||||||
Numerator:
|
||||||||||
Income
from continuing operations
|
$
|
56,042
|
$
|
37,355
|
$
|
13,371
|
||||
Preferred
stock dividends
|
(9,923
|
)
|
(11,385
|
)
|
(15,807
|
)
|
||||
Preferred
stock conversion/redemption charges
|
—
|
(2,013
|
)
|
(41,054
|
)
|
|||||
Numerator
for income (loss) available to common from continuing operations
- basic
and diluted
|
46,119
|
23,957
|
(43,490
|
)
|
||||||
(Loss)
gain from discontinued operations
|
(345
|
)
|
1,398
|
6,775
|
||||||
Numerator
for net income (loss) available to common per share - basic and
diluted
|
$
|
45,774
|
$
|
25,355
|
$
|
(36,715
|
)
|
|||
Denominator:
|
||||||||||
Denominator
for net income per share - basic
|
58,651
|
51,738
|
45,472
|
|||||||
Effect
of dilutive securities:
|
||||||||||
Restricted
stock and restricted stock units
|
74
|
86
|
—
|
|||||||
Stock
option incremental shares
|
20
|
235
|
—
|
|||||||
Denominator
for net income per share - diluted
|
58,745
|
52,059
|
45,472
|
Earnings
per share - basic:
|
||||||||||
Income
(loss) available to common from continuing operations
|
$
|
0.79
|
$
|
0.46
|
$
|
(0.96
|
)
|
|||
Income
(loss) from discontinued operations
|
(0.01
|
)
|
0.03
|
0.15
|
||||||
Net
income (loss) per share - basic
|
$
|
0.78
|
$
|
0.49
|
$
|
(0.81
|
)
|
|||
Earnings
per share - diluted:
|
||||||||||
Income
(loss) available to common from continuing operations
|
$
|
0.79
|
$
|
0.46
|
$
|
(0.96
|
)
|
|||
Income
(loss) from discontinued operations
|
(0.01
|
)
|
0.03
|
0.15
|
||||||
Net
income (loss) per share - diluted
|
$
|
0.78
|
$
|
0.49
|
$
|
(0.81
|
)
|
Year
Ended December 31,
|
||||||||||
2006
|
2005
|
2004
|
||||||||
(in
thousands)
|
||||||||||
Revenues
|
||||||||||
Rental
income
|
$
|
372
|
$
|
4,443
|
$
|
6,121
|
||||
Other
income
|
—
|
24
|
53
|
|||||||
Subtotal
revenues
|
372
|
4,467
|
6,174
|
|||||||
Expenses
|
||||||||||
Depreciation
and amortization
|
150
|
1,421
|
2,709
|
|||||||
General
and Administrative
|
40
|
—
|
—
|
|||||||
Provision
for uncollectible accounts receivable
|
152
|
—
|
—
|
|||||||
Provisions
for impairment
|
541
|
9,617
|
—
|
|||||||
Subtotal
expenses
|
883
|
11,038
|
2,709
|
|||||||
(Loss)
income before gain on sale of assets
|
(511
|
)
|
(6,571
|
)
|
3,465
|
|||||
Gain
on assets sold - net
|
166
|
7,969
|
3,310
|
|||||||
(Loss)
gain from discontinued operations
|
$
|
(345
|
)
|
$
|
1,398
|
$
|
6,775
|
SCHEDULE
III REAL ESTATE AND ACCUMULATED DEPRECIATION
|
|
|||||||||||
December
31, 2006
|
(3)
|
|||||||||||||||||||||||||||||||
Gross
Amount at
Which Carried
|
|||||||||||||||||||||||||||||||
Cost
Capitalized
|
at
Close of
|
Life
on
Which
|
|||||||||||||||||||||||||||||
Initial
Cost to
|
Subsequent
|
Period
|
Depreciation
|
||||||||||||||||||||||||||||
Company
|
to
|
Buildings
|
in
Latest
|
||||||||||||||||||||||||||||
Buildings
|
Acquisition
|
and
Land
|
(4)
|
Income
|
|||||||||||||||||||||||||||
and
Land
|
Improvements
|
Accumulated
|
Date
of
|
Date
|
Statements
|
||||||||||||||||||||||||||
Description
(1)
|
Encumbrances
|
Improvements
|
Improvements
|
Impairment
|
Other
|
Total
|
Depreciation
|
Renovation
|
Acquired
|
is
Computed
|
|||||||||||||||||||||
Sun
Healthcare Group, Inc.:
|
|||||||||||||||||||||||||||||||
Alabama
(LTC)
|
(2)
|
|
23,584,956
|
-
|
-
|
-
|
23,584,956
|
6,628,477
|
1997
|
33
years
|
|||||||||||||||||||||
California
(LTC, RH)
|
(2)
|
|
39,013,223
|
66,575
|
-
|
-
|
39,079,798
|
10,277,900
|
1964
|
1997
|
33
years
|
||||||||||||||||||||
Colorado
(LTC, AL)
|
|
38,563,002
|
38,563,002
|
429,694
|
2006
|
39
years
|
|||||||||||||||||||||||||
Idaho
(LTC)
|
(2)
|
|
21,776,277
|
-
|
-
|
-
|
21,776,277
|
2,635,608
|
1997-1999
|
33
years
|
|||||||||||||||||||||
Massachusetts
(LTC)
|
(2)
|
|
8,300,000
|
-
|
-
|
-
|
8,300,000
|
2,352,366
|
1997
|
33
years
|
|||||||||||||||||||||
North
Carolina (LTC)
|
(2)
|
|
22,652,488
|
56,951
|
-
|
-
|
22,709,439
|
8,389,556
|
1982-1991
|
1994-1997
|
30
years to 33 years
|
||||||||||||||||||||
Ohio
(LTC)
|
(2)
|
|
11,653,451
|
20,247
|
-
|
-
|
11,673,698
|
3,129,164
|
1995
|
1997
|
33
years
|
||||||||||||||||||||
Tennessee
(LTC)
|
(2)
|
|
7,905,139
|
37,234
|
-
|
-
|
7,942,373
|
3,064,951
|
1994
|
30
years
|
|||||||||||||||||||||
Washington
(LTC)
|
(2)
|
|
10,000,000
|
1,798,843
|
-
|
-
|
11,798,843
|
5,536,845
|
2005
|
1995
|
20
years
|
||||||||||||||||||||
West
Virginia (LTC)
|
(2)
|
|
24,751,206
|
42,238
|
-
|
-
|
24,793,444
|
6,481,373
|
1997-1998
|
33
years
|
|||||||||||||||||||||
Total
Sun
|
208,199,742
|
2,022,088
|
-
|
-
|
210,221,830
|
48,925,934
|
|||||||||||||||||||||||||
CommuniCare
Health Services:
|
|||||||||||||||||||||||||||||||
Ohio
(LTC, AL)
|
$
|
165,003,208
|
$
|
531,383
|
$
|
-
|
$
|
-
|
$
|
165,534,591
|
$
|
9,730,829
|
1998-2005
|
33
years to 39 years
|
|||||||||||||||||
Pennsylvania
(LTC)
|
20,286,067
|
-
|
-
|
-
|
20,286,067
|
890,649
|
2005
|
39
years
|
|||||||||||||||||||||||
Total
CommuniCare
|
185,289,275
|
531,383
|
-
|
-
|
185,820,658
|
10,621,478
|
|||||||||||||||||||||||||
Haven
Healthcare:
|
|||||||||||||||||||||||||||||||
Connecticut
(LTC)
|
38,762,737
|
1,648,475
|
(4,958,643
|
)
|
-
|
35,452,569
|
5,712,272
|
1999-2004
|
33
years to 39 years
|
||||||||||||||||||||||
Massachusetts
(LTC)
|
7,190,684
|
-
|
-
|
-
|
7,190,684
|
174,170
|
2006
|
39
years
|
|||||||||||||||||||||||
New
Hampshire (LTC, AL)
|
21,619,505
|
-
|
-
|
-
|
21,619,505
|
1,906,502
|
1998
|
39
years
|
|||||||||||||||||||||||
Rhode
Island (LTC)
|
38,739,811
|
-
|
-
|
-
|
38,739,811
|
983,813
|
2006
|
39
years
|
|||||||||||||||||||||||
Vermont
(LTC)
|
14,145,776
|
81,501
|
-
|
-
|
14,227,277
|
953,787
|
2004
|
39
years
|
|||||||||||||||||||||||
Total
Haven
|
120,458,513
|
1,729,976
|
(4,958,643
|
)
|
-
|
117,229,846
|
9,730,544
|
||||||||||||||||||||||||
HQM,
Inc.:
|
|||||||||||||||||||||||||||||||
Florida
(LTC)
|
85,805,338
|
1,791,201
|
-
|
-
|
87,596,539
|
7,365,547
|
1998-2006
|
33
years to 39 years
|
|||||||||||||||||||||||
Kentucky
(LTC)
|
10,250,000
|
522,075
|
-
|
-
|
10,772,075
|
2,162,919
|
1999
|
33
years
|
|||||||||||||||||||||||
Total
HQM
|
96,055,338
|
2,313,276
|
-
|
-
|
98,368,614
|
9,528,466
|
|||||||||||||||||||||||||
SCHEDULE
III REAL ESTATE AND ACCUMULATED DEPRECIATION
|
|
|||||||||||
December
31, 2006
|
(3)
|
|||||||||||||||||||||||||||||||
Gross
Amount at
Which Carried
|
|||||||||||||||||||||||||||||||
Cost
Capitalized
|
at
Close of
|
Life
on
Which
|
|||||||||||||||||||||||||||||
Initial
Cost to
|
Subsequent
|
Period
|
Depreciation
|
||||||||||||||||||||||||||||
Company
|
to
|
Buildings
|
in
Latest
|
||||||||||||||||||||||||||||
Buildings
|
Acquisition
|
and
Land
|
(4)
|
Income
|
|||||||||||||||||||||||||||
and
Land
|
Improvements
|
Accumulated
|
Date
of
|
Date
|
Statements
|
||||||||||||||||||||||||||
Description
(1)
|
Encumbrances
|
Improvements
|
Improvements
|
Impairment
|
Other
|
Total
|
Depreciation
|
Renovation
|
Acquired
|
is
Computed
|
Advocat,
Inc.:
|
|||||||||||||||||||||||||||||||
Alabama
(LTC)
|
11,588,534
|
808,961
|
-
|
-
|
12,397,495
|
5,272,456
|
1975-1985
|
1992
|
31.5
years
|
||||||||||||||||||||||
Arkansas
(LTC)
|
36,052,810
|
6,122,100
|
(36,350
|
)
|
-
|
42,138,560
|
16,480,644
|
1984-1985
|
1992
|
31.5
years
|
|||||||||||||||||||||
Florida
(LTC)
|
1,050,000
|
1,920,000
|
(970,000
|
)
|
-
|
2,000,000
|
316,749
|
1992
|
31.5
years
|
||||||||||||||||||||||
Kentucky
(LTC)
|
15,151,027
|
1,562,375
|
-
|
-
|
16,713,402
|
5,829,700
|
1972-1994
|
1994-1995
|
33
years
|
||||||||||||||||||||||
Ohio
(LTC)
|
5,604,186
|
250,000
|
-
|
-
|
5,854,186
|
2,063,913
|
1984
|
1994
|
33
years
|
||||||||||||||||||||||
Tennessee
(LTC)
|
9,542,121
|
-
|
-
|
-
|
9,542,121
|
4,209,458
|
1986-1987
|
1992
|
31.5
years
|
||||||||||||||||||||||
West
Virginia (LTC)
|
5,437,221
|
348,642
|
-
|
-
|
5,785,863
|
2,013,545
|
1994-1995
|
33
years
|
|||||||||||||||||||||||
Total
Advocat
|
84,425,899
|
11,012,078
|
(1,006,350
|
)
|
-
|
94,431,627
|
36,186,465
|
||||||||||||||||||||||||
Guardian
LTC Management, Inc.
|
|||||||||||||||||||||||||||||||
Ohio
(LTC)
|
6,548,435
|
-
|
-
|
-
|
6,548,435
|
329,329
|
2004
|
39
years
|
|||||||||||||||||||||||
Pennsylvania
(LTC, AL)
|
75,436,912
|
-
|
-
|
-
|
75,436,912
|
3,613,671
|
2004-2006
|
39
years
|
|||||||||||||||||||||||
West
Virginia (LTC)
|
3,995,581
|
-
|
-
|
-
|
3,995,581
|
196,253
|
2004
|
39
years
|
|||||||||||||||||||||||
Total
Guardian
|
85,980,928
|
-
|
-
|
-
|
85,980,928
|
4,139,253
|
|||||||||||||||||||||||||
Nexion
Health:
|
|||||||||||||||||||||||||||||||
Louisiana
(LTC)
|
(2)
|
|
55,638,965
|
-
|
-
|
-
|
55,638,965
|
1,943,222
|
1997
|
33
years
|
|||||||||||||||||||||
Texas
(LTC)
|
24,571,806
|
-
|
-
|
-
|
24,571,806
|
550,590
|
2005-2006
|
39
years
|
|||||||||||||||||||||||
Total
Nexion Health
|
80,210,771
|
-
|
-
|
-
|
80,210,771
|
2,493,812
|
|||||||||||||||||||||||||
Essex
Healthcare:
|
|||||||||||||||||||||||||||||||
Ohio
(LTC)
|
79,353,622
|
-
|
-
|
-
|
79,353,622
|
4,177,705
|
2005
|
39
years
|
|||||||||||||||||||||||
Total
Essex
|
79,353,622
|
-
|
-
|
-
|
79,353,622
|
4,177,705
|
|||||||||||||||||||||||||
Other:
|
|||||||||||||||||||||||||||||||
Arizona
(LTC)
|
24,029,032
|
1,863,709
|
(6,603,745
|
)
|
-
|
19,288,996
|
4,433,829
|
2005
|
1998
|
33
years
|
|||||||||||||||||||||
California
(LTC)
|
(2)
|
|
20,577,181
|
1,008,313
|
-
|
-
|
21,585,494
|
5,513,220
|
1997
|
33
years
|
|||||||||||||||||||||
Colorado
(LTC)
|
14,170,968
|
196,017
|
-
|
-
|
14,366,985
|
3,301,966
|
1998
|
33
years
|
|||||||||||||||||||||||
Florida
(LTC, AL)
|
58,367,881
|
746,398
|
-
|
-
|
59,114,279
|
11,479,569
|
1993-1998
|
27
years to 37.5 years
|
|||||||||||||||||||||||
Georgia
(LTC)
|
10,000,000
|
-
|
-
|
-
|
10,000,000
|
921,291
|
1998
|
37.5
years
|
|||||||||||||||||||||||
Illinois
(LTC)
|
13,961,501
|
444,484
|
-
|
-
|
14,405,985
|
3,872,888
|
1996-1999
|
30
years to 33 years
|
|||||||||||||||||||||||
Indiana
(LTC, AL)
|
15,142,300
|
2,305,705
|
(1,843,400
|
)
|
-
|
15,604,605
|
4,941,517
|
1980-1994
|
1992-1999
|
30
years to 33 years
|
|||||||||||||||||||||
Iowa
(LTC)
|
14,451,576
|
1,280,688
|
(29,156
|
)
|
-
|
15,703,108
|
4,071,865
|
1996-1998
|
30
years to 33 years
|
||||||||||||||||||||||
Massachusetts
(LTC)
|
30,718,142
|
932,328
|
(8,257,521
|
)
|
-
|
23,392,949
|
5,138,955
|
1999
|
33
years
|
||||||||||||||||||||||
Missouri
(LTC)
|
12,301,560
|
-
|
(149,386
|
)
|
-
|
12,152,174
|
2,788,561
|
1999
|
33
years
|
||||||||||||||||||||||
Ohio
(LTC)
|
2,648,252
|
186,187
|
-
|
-
|
2,834,439
|
658,159
|
1999
|
33
years
|
|||||||||||||||||||||||
Pennsylvania
(LTC)
|
14,400,000
|
-
|
-
|
-
|
14,400,000
|
3,716,661
|
2005
|
39
years
|
|||||||||||||||||||||||
Texas
(LTC)
|
(2)
|
|
55,662,091
|
1,361,842
|
-
|
-
|
57,023,933
|
10,312,566
|
1997-2005
|
33
years to 39 years
|
|||||||||||||||||||||
Washington
(AL)
|
5,673,693
|
-
|
-
|
-
|
5,673,693
|
1,232,807
|
1999
|
33
years
|
|||||||||||||||||||||||
Total
Other
|
292,104,177
|
10,325,671
|
(16,883,208
|
)
|
-
|
285,546,640
|
62,383,854
|
||||||||||||||||||||||||
Total
|
$
|
1,232,078,265
|
$
|
27,934,472
|
($22,848,201
|
)
|
$
|
0
|
$
|
1,237,164,536
|
$
|
188,187,511
|
|||||||||||||||||||
(1)
The real estate included in this schedule is being used in either
the
operation of long-term care facilities (LTC), assisted living facilities
(AL) or
rehabilitation hospitals (RH) located in the states
indicated.
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
(2)
Certain of the real estate indicated are security for the BAS Healthcare
Financial Services line of credit and term loan borrowings totaling
$150,000,000 at December 31, 2006.
|
|||||||||||||||||||||||||||||||
Year
Ended December 31,
|
|||||||||||||||||||||||||||||||
(3)
|
2004
|
|
|
2005
|
|
|
2006
|
||||||||||||||||||||||||
Balance
at beginning of period
|
$
|
599,654,665
|
$
|
720,368,296
|
$
|
990,492,285
|
|||||||||||||||||||||||||
Additions
during period:
|
|||||||||||||||||||||||||||||||
Acquisitions
|
114,286,825
|
252,609,901
|
178,906,047
|
||||||||||||||||||||||||||||
Conversion
from mortgage
|
-
|
13,713,311
|
-
|
||||||||||||||||||||||||||||
Impairment
|
-
|
-
|
-
|
||||||||||||||||||||||||||||
Improvements
|
6,426,806
|
3,821,320
|
6,817,638
|
||||||||||||||||||||||||||||
Consolidation
under FIN 46R (a)
|
-
|
-
|
61,750,000
|
||||||||||||||||||||||||||||
Disposals/other
|
-
|
(20,543
|
)
|
(801,434
|
)
|
||||||||||||||||||||||||||
Balance
at close of period
|
$
|
720,368,296
|
$
|
990,492,285
|
$
|
1,237,164,536
|
|||||||||||||||||||||||||
_______________________________
(a)
As a result of the application of FIN 46R in 2006, we consolidated
an
entity determined to be a VIE for which we are the primary beneficiary.
Our consolidated balance sheet at December 31, 2006 reflects gross
real
estate assets of $61,750,000, reflecting the real estate owned
by the
VIE.
|
|||||||||||||||||||||||||||||||
(4)
|
2004
|
2005
|
2006
|
||||||||||||||||||||||||||||
Balance
at beginning of period
|
$
|
114,305,220
|
$
|
132,727,879
|
$
|
156,197,300
|
|||||||||||||||||||||||||
Additions
during period:
|
|||||||||||||||||||||||||||||||
Provisions
for depreciation
|
18,422,659
|
23,469,421
|
31,990,211
|
||||||||||||||||||||||||||||
Provisions
for depreciation, Discontinued Ops.
|
-
|
||||||||||||||||||||||||||||||
Dispositions/other
|
-
|
||||||||||||||||||||||||||||||
Balance
at close of period
|
$
|
132,727,879
|
$
|
156,197,300
|
$
|
188,187,511
|
|||||||||||||||||||||||||
The
reported amount of our real estate at December 31, 2006 is less
than the
tax basis of the real estate by approximately $39.0
million.
|
SCHEDULE
IV MORTGAGE LOANS ON REAL ESTATE
|
||||||||||
December
31, 2006
|
Description
(1)
|
|
Interest
Rate
|
|
Final
Maturity Date
|
|
Periodic
Payment Terms
|
|
Prior
Liens
|
|
Face
Amount of Mortgages
|
|
Carrying
Amount of Mortgages (2)
(3)
|
|
Principal
Amount of Loans Subject to Delinquent Principal or
Interest
|
||||||||
Florida
(4 LTC facilities)
|
11.50%
|
|
February
28, 2010
|
Interest
plus $4,400 of principal payable monthly
|
None
|
12,891,454
|
12,587,005
|
|||||||||||||||
Florida
(2 LTC facilities)
|
11.50%
|
|
June
1, 2016
|
Interest
payable monthly
|
None
|
12,590,000
|
10,730,939
|
|||||||||||||||
Ohio
(1 LTC facility)
|
11.00%
|
|
October
31, 2014
|
Interest
plus $3,900 of principal payable monthly
|
None
|
6,500,000
|
6,453,694
|
|||||||||||||||
Texas
(1 LTC facility)
|
11.00%
|
|
November
30, 2011
|
Interest
plus $19,900 of principal payable monthly
|
None
|
2,245,745
|
1,229,971
|
|||||||||||||||
Utah
(1 LTC facility)
|
12.00%
|
|
November
30, 2011
|
Interest
plus $20,800 of principal payable monthly
|
None
|
1,917,430
|
884,812
|
|||||||||||||||
$
|
36,144,629
|
$
|
31,886,421
|
|||||||||||||||||||
(1)
Mortgage loans included in this schedule represent first mortgages
on
facilities used in the delivery of long-term healthcare of which
such
facilities are located in the states indicated.
|
||||||||||||||||||||||
(2)
The aggregate cost for federal income tax purposes is equal to
the
carrying amount.
|
|
Year
Ended December 31,
|
|||||||||||||||||||||
(3)
|
2004
|
2005
|
2006
|
|||||||||||||||||||
Balance
at beginning of period
|
$
|
119,783,915
|
$
|
118,057,610
|
$
|
104,522,341
|
||||||||||||||||
Additions
during period - Placements
|
6,500,000
|
61,750,000
|
-
|
|||||||||||||||||||
Deductions
during period - collection of principal/other
|
(8,226,305
|
)
|
(61,571,958
|
)
|
(10,885,920
|
)
|
||||||||||||||||
Allowance
for loss on mortgage loans
|
-
|
-
|
-
|
|||||||||||||||||||
Conversion
to purchase leaseback
|
-
|
(13,713,311
|
)
|
-
|
||||||||||||||||||
Consolidation
under FIN 46R (a)
|
-
|
-
|
(61,750,000
|
)
|
||||||||||||||||||
Balance
at close of period
|
$
|
118,057,610
|
$
|
104,522,341
|
$
|
31,886,421
|
||||||||||||||||
(a)
As a result of the application of FIN 46R in 2006, we consolidated
an
entity that was the debtor of a mortgage note with us for $61,750,000
as
of December 31, 2005.
|